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With an increasing population density throughout the world and the current drive to provide 
fresh water to as many people as possible, innovative methods of providing safe drinking water 
are in very high demand. In 2002, the United Nations stated in their millennium declaration 
that one of their priority goals was “to halve, by the year 2015, the proportion of people who 
are unable to reach or to afford safe drinking water” (UNESCO, 2000). This goal was set with 
high standards, and will require a great deal of water treatment related research in the short 
coming years. 
 
Over the past two decades, drinking water treatment via membrane filtration has been widely 
accepted as a feasible alternative to conventional drinking water treatment. Membrane 
processes are used in environmental, chemical, food, beverage, pharmaceutical, and various 
other industries for separation applications. Since the early 1990’s, there has been rapid growth 
in the use of low-pressure hollow fibre membrane processes for the production of drinking 
water. These membrane systems are increasingly being accepted as feasible technologies for 
drinking water treatment. 
 
Like with any innovative process, it has limitations; the primary limitation being membrane 
fouling, which is an accumulation of particles on the surface and inside the pores of the 
membrane surface. Membrane fouling has the ability to reduce the flux, in doing so, requiring 
a higher pumping intensity to maintain a consistent volume of water being treated. This project 
investigated chemical coagulation as a pre-treatment to membrane ultra-filtration, with the 
goal of mitigating fouling impact in order to maintain a consistent permeate flux, while 
monitoring several water quality parameters before and after treatment such as turbidity, 
alkalinity, pH and total organic carbon (TOC). 
 
Two different raw water sources were studied: Grand River water taken from the Hidden 
Valley intake, located in Kitchener, ON, and Lake Ontario water taken from the Woodward 
Water Treatment Plant in Hamilton, ON. The evaluated coagulants include alum and ferric 
chloride, which are widely used hydrolyzing metal salt (HMS) coagulants; and three 
polyaluminum chloride (PACl) products, which are pre-hydrolyzed coagulants formed by the 
controlled neutralization of aluminum chloride solution. 
 
Phase 1 of the project involved the coagulation of water using various aluminum and iron-
based coagulants. Synthetic water was used at the outset, followed by the use of raw water 
obtained from two water treatment plants: one on the Grand River and one on Lake Ontario. A 
series of jar test trials was conducted to determine optimum coagulant dosages for the removal 
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of NOM. These doses were then used as a baseline for subsequent membrane trials in phase 2 
of this project. 
 
Phase 2 involved the treatment of raw and coagulated waters with a hollow fibre bench scale 
UF unit (Zenon Environmental Inc.®, ZeeWeed-1).  Membrane trials were performed with the 
coagulants applied at optimal and sub optimal dosages in order to evaluate the integrated 
process for mitigation of organic fouling. As all trials were conducted at a constant flowrate, 
membrane fouling was evaluated by monitoring trans-membrane pressure (TMP) over time.  
 
The raw and treated water were fractionated to obtain quantitative information on the size 
components of NOM contributing most to fouling. Results will be presented comparing how 
the different coagulants affected the concentration of each NOM MW fraction in the raw and 
treated waters. 
 
Collectively, results showed that all four coagulants substantially decreased the rate of TMP 
increase, particularly with the Grand River water which contained much higher turbidity and 
TOC concentrations than the Lake Ontario water. During the trials conducted with Grand 
River, alum performed best, reducing the TMP by 57 % over a 3-day period. The PACl 
coagulants performed best at reducing the TMP during the Lake Ontario membrane trials; 
reducing the TMP by 21 % and 19 % for SP 70 and SP respectively. The system’s ability to 
maintain a permeate turbidity level of 0.1 NTU or lower was met, and TOC removals varied a 
small amount across the four coagulants, ranging from 45-65 % and 15-35 % for the Grand 
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CHAPTER 1  
 
INTRODUCTION 
1.1 The Growing Need for Clean Drinking Water 
In most countries, water is everywhere. Unfortunately, however, ninety-seven percent of the 
world’s total water is seawater. Of the remaining fresh water, two-thirds of this fresh water is 
locked in glaciers, ice or snow, leaving only one percent of the world’s total water available for 
direct human consumption. Presently, there is a greater demand than ever before for safe 
drinking water – not only in North America, but throughout the entire world (MWH, 2005). A 
generally accepted definition of safe drinking water is water that is free of pathogenic organisms, 
toxic substances, colour, turbidity, taste and odour, and has an acceptable level of minerals and 
organic material (WHO, 2004).  
 
The use of low pressure membrane systems has become a widely accepted addition to 
conventional drinking water treatment. The process has received a great deal of attention, and in 
many ways, it is a proven, sustainable, and reliable treatment technology used on a variety of 
scales around the world. In the United States alone, the growing demand for membrane treatment 
technology such as reverse osmosis (RO), micro-filtration and ultra-filtration, in all water 
treatment applications rose 6.5 percent annually starting in 1994, reaching $305 million in the 
year 2001 (Vial and Doussau, 2002), and considerable further growth has been seen since. The 
process provides water treatment through physico-chemical separation techniques that use 
differences in permeability and physical blocking of the water constituents as a separation 
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mechanism. Conceptually, it is a reasonably simple technology to understand that has the 
capacity to achieve high standards of treatment over long periods of time. The use of membranes 
has been somewhat limited due to high capital costs, although in recent years the cost of 
membrane systems has decreased substantially. Laîné et al. (2000) reported that between 1992 
and 2000, a 50 % decrease in cost was observed, with further decreases in cost observed since. 
This decrease in cost has been mainly attributed to two factors: an increase in membrane surface 
area per module and an increase in mass production of these membrane modules. As a result of 
the decreased cost, the use of these systems has seen increased usage over the past 20 years, to 
become a very attractive and feasible alternative to conventional drinking water treatment.  One 
of the primary limitations to even wider acceptance of membrane systems is the reversible and 
irreversible fouling that occurs on the membrane. The organic matter that is important for such 
fouling exists in both suspended and dissolved forms, with the dissolved components causing 
both organic and biological fouling which are difficult to treat, as compared to the colloidal 
(suspended particulate) fouling which can be mitigated with the use of cyclic back-wash cycles 
(AWWA, 2005). 
 
1.2  Research Objectives 
The primary goal of this research was to investigate the effectiveness of various chemical 
coagulation conditions as a pre-treatment to ultra-filtration (UF) hollow fibre membranes for 
mitigation of fouling caused by particulate matter and natural organic matter (NOM). 
 
The following is a list of specific objectives: 
• Optimize coagulation by determining suitable coagulant doses to reduce the 
concentration of particulate matter (turbidity) and NOM prior to being treated by the UF 
membrane. 
• Develop a laboratory scale setup in which coagulation is incorporated with a hollow-fibre 
UF membrane process to yield a more consistent flux across the membrane surface. 
• Compare the fouling reduction potential of the different coagulation scenarios. 
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• Fractionate the raw and treated water into a series of molecular weight cut-off (MWCO) 
fractions, to assist in quantifying what portions of the natural organic matter (NOM) were 
removed with the settled flocs and/or remained on the surface of the membrane 
1.3 Research Approach 
After an extensive literature review was completed, the experimental design was divided into 
two phases: 
Phase I: The first part of the work was the coagulation of synthetic water containing a 
specified amount of NOM in the form of Sigma-Aldrich® humic acid. The project 
explored two different source waters found in Southern Ontario: Grand River, and 
Lake Ontario. At the outset, coagulation trials were performed using a variety of 
synthetic water conditions including those relevant for these waters. These 
experiments were followed by trials using raw water obtained from the water sources 
mentioned above. 
Phase II: a) The second part of the project involved the treatment of these raw water sources 
with a ZeeWeed-1® hollow fibre bench test unit. In order to further understand the 
NOM fouling process, both the raw and coagulated waters were treated with the UF 
membrane. 
Phase II: b) Subsequent to the membrane filtration, both the treated and raw waters 
were fractionated to analyze what molecular weight fractions of the NOM were 
removed by the overall process (coagulation/flocculation/settling/membrane). 
Although not possible in this research because of time constraints, if a fractionation 
analysis of the flocculated water were included, this approach could determine how 
the fractions contributed to the permeate flux reduction across the membrane. 
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1.4 Thesis Layout 
This thesis document has been prepared to be read by one with very little knowledge in the area 
of drinking water treatment, and more specifically membrane treatment technology. It is the hope 
of the author that after having read the literature review provided in Chapter 2, one would be 
sufficiently informed to be able to follow the remainder of the dissertation. The literature review 
presents background information on low pressure treatment systems, coagulation, and the 
combination of the two. 
 
Chapter 3 of this dissertation contains information on experimental design and analytical 
methods. The subsequent chapters provide results detailing the coagulation work that was 
completed, as well the membrane filtration of waters pre-treated with a variety of coagulants.  
 
Chapters 4 and 5 contain summaries of the results and corresponding analysis. The principal 
conclusions and recommendations are laid out in Chapter 6. The subsequent section contains a 
complete reference list for all sourced information in the thesis. The last section of this document 

















CHAPTER 2  
 
LITERATURE REVIEW AND BACKGROUND  
2.1 The Present State of Affairs 
The world population has grown tremendously in the last 20 years, to reach a total of over 6.5 
billion people, as of the beginning of 2006 (USCB, 2006). Improving access to safe drinking 
water has just barely kept ahead of population growth during the 1990’s, and as a result the 
percentage of those without access to safe drinking water dropped from 25 % in 1996 to 18 % in 
2003. Having said this, more than one billion people still remain without safe drinking water and 
over two billion lack adequate sources of sanitation. The global need for access to clean drinking 
water is rising at an alarming rate. The World Health Organization (WHO, 2004) has labelled it 
as a “silent emergency”, as billions of people struggle without clean water or basic sanitation 
(WHO and UNICEF, 2004). 
 
The need for advanced drinking water treatment technologies is on the rise. Although Canadians 
have ample water supplies in general, it is important to note that the best way to make sure 
drinking water supplies are kept clean, safe and reliable is to take a preventive risk management 
approach, or as it is often referred, a multiple barrier approach (MBA).A MBA is a series of 
checks and balances from the watershed to the tap of the customer. It is considered, in the water 
utility profession, to be the most effective way to ensure public health protection. Conventional 
drinking water treatment in Canada generally consists of several distinct stages: filtration, 
coagulation, flocculation, sedimentation and disinfection, not necessarily in that order. These 
practices have been in place for several decades, and these conventional plants are becoming less 
common due to the stringent water quality regulations that are being passed. The use of low 
pressure membranes to treat contaminated water has been widely accepted as a feasible 
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alternative, and therefore must be explored even more so in the future to allow for sustainable 
treatment technologies, both for metropolitan and small communities. 
 
2.2 Background on Membrane Treatment 
2.2.1 History and evolution of membrane treatment processes 
Micro-porous membranes were first used and patented in the 1920’s (Belfort et al., 1994), 
although they were limited primarily to laboratory use until the 1950’s. Initially, they were used 
for enumerating bacteria, removing microorganisms and particles from liquid and gas streams, 
and fractioning and sizing macro-molecules such as proteins (MWH, 2005). In the 1950’s 
industries began incorporating membrane filtration, primarily for the sterilization of liquid 
pharmaceuticals and intravenous solutions. Membrane filtration also slowly began to be used for 
industrial waste treatment, in order to separate oils, fats, acids and brine. 
 
There are four main categories of membranes used in drinking water applications today: micro-
filtration (MF), ultra-filtration (UF), nano-filtration (NF) and reverse osmosis (RO). These 
membranes are generally classified by pore size, molecular weight cut-off (MWCO) and the 
applied pressure that they require. Pore size is sometimes expressed as MWCO, which is a 
measure of the removal characteristics of a membrane in terms of atomic weight or mass, as 
opposed to pore size; typically measured in daltons (AWWA, 2005). Table 2-1 provides a 

















Primary applications Microbes removed
RO 1000-5000 ≥ 0.0001
Removal of monovalent 
ions (desalination)










Algae, protozoa and 
most bacteria
Removal of dissolved 
nonionic solutes
Algae, protozoa, most 
bacteria and viruses
Removal of divalent ions 
(softening) and dissolved 
organic matter
Algae, protozoa, most 
bacteria and viruses
Removal of particles and 
turbidity
 
Adapted from Taylor and Weisner (1999) 
 
The membrane modules themselves are a part of a larger system which includes all of the 
operational concepts and conditions that make up a treatment system (Schäfer et al., 2005). 
 
Membrane processes now are used in environmental, chemical, food, beverage, pharmaceutical, 
and various other industries for separation applications. In water and wastewater treatment, their 
application as an advanced physical process for clarification and disinfection is established and 
rapidly gaining popularity (Sethi et al., 2000). Since the early 1990’s, there has been rapid 
growth in the use of low-pressure micro-filtration (MF) and ultra-filtration (UF) membrane 
processes for the production of drinking water. Specifically, UF membranes are very successful 
in removing turbidity, which is generally defined as a measure of the cloudiness of water; the 
cloudier the water, the greater the turbidity. Turbidity in water is caused by suspended matter 
such as clay, silt, organic matter, plankton and other microscopic organisms that interfere with 
the passage of light through the water (American Public Health Association, 1998). Turbidity is 
an indicator of major sources of water impurities in waters (including those in Canada), and 
therefore is an ongoing parameter of interest for all water treatment processes. The UF 
membranes can yield permeate streams consistently with turbidity values of less than 0.1 NTU 
(Nephlometric Turbidity Unit).  
 
The widespread growth of the use of low pressure membrane systems on large scale applications 
has occurred for several reasons. A major reason is the changes in the regulatory requirements 
for drinking water in Canada, requiring lower filtered water turbidity and removal of chemical 
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disinfectant-tolerant micro-organisms, such as Giardia and especially Cryptosporidium 
(AWWA, 2005). Figure 2-1 shows the tremendous growth in the use of membrane technology in 




























































































































Figure 2-1: The growth in the use of membrane technology (AWWA, 2005) 
 
This trend is continuing at a rapid rate as numerous membrane facilities ranging from 25 to 100 
mgd (100 to 380 mLd) in capacity, are either planned, in design or in operation.  
 
Another major cause for the recent expansion in membrane systems utilization is simply the 
broader applicability that they offer as compared to conventional drinking water treatment. MF 
and UF systems are particulate filters and unlike nano-filtration (NF) and reverse osmosis (RO) 
do not remove dissolved constituents. This treatment aspect makes them more suitable for use as 
a replacement to conventional filters. The cost of low pressure membranes systems is also a 
major driver for increased membrane application compared with conventional treatment 
technologies. Every year, the capital cost of MF and UF systems has decreased as economies of 
scale and a competitive market force innovative developments. Generally, low pressure 
membrane facilities are one half to one third the cost of an NF or RO facility (Farahbakhsh et al., 
2004). In addition, the implementation of innovative backwash or cleaning strategies has reduced 
operational cost, by reducing the degree of fouling that occurs on the surface and inside the pores 
of the membranes. 
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One other key factor that has increased the usage of membrane systems is their operational 
flexibility. These systems can be used in conjunction with other treatment processes to achieve 
additional removal. There are several pre-treatment techniques available to use in combination 
with a MF or UF membrane: pre-filtration, pH adjustment, coagulation, bio-filtration adsorption 
and pre-oxidation (Kimura et al., 2005). 
2.2.2 Description of membrane treatment processes 
Process Description 
Low pressure membrane processes are generally used for the removal of turbidity in water, and 
reasonably large pathogens such as Cryptosporidium and Giardia, and most bacteria (Klijn et al., 
2000). The MF process is not very effective at removing NOM (Jacangelo et al., 1997), as these 
compounds are more efficiently targeted by ultra-filtration (UF) processes and much more 
efficiently by nano-filtration (NF). The two major issues that utilities have to deal with on a 
regular basis with UF membrane processes are the quality of the water product, which is related 
to the rejection of targeted solutes and particulates, and the impact of membrane fouling leading 
to permeate flux decline and consequent reduction in the efficiency of the membrane filtration 
process (Linhua et al., 2001). 
 
Membrane processes are modern physicochemical separation techniques that use differences in 
permeability and size of contaminant as a separation mechanism (MWH, 2005). Effective 
membrane treatment will remove all or most of the contaminants to produce a water which, with 
effective disinfection, is of minimum risk to human health, aesthetically acceptable, and 
economically affordable (Westerhoff et al., 1996). Figure 2-2 shows a simplified form of a 
membrane process system, represented by the rectangle, which would in practice be a membrane 
module with a specified surface area. The basic principle of a cross-flow membrane system is as 
follows: raw water enters the module, where an applied pressure allows water with particles and 
molecules smaller that the specified pore size to pass through the membrane creating a permeate 
stream, while the remaining materials travel along the outer surface of the membrane, eventually 




Figure 2-2 Schematic of separation process through semi-permeable membrane 
Adapted from MWH (2005) 
 
During the treatment process, the contaminated raw water is fed into the membrane module via a 
pump, which ensures that water is drawn through by vaccum. This pressurized water is fed into 
the membrane module, and onto the membrane surface. Generally, the feed stream flows 
perpendicularly to the membrane surface, although in some cases, the water is top-loaded onto 
the surface, called dead-end filtration. This set-up is no longer a common practice, as it induces 
membrane fouling much more than the modern approach of the cross-flow filtration. The 
membrane is described as semi-permeable, meaning that it is highly permeable to some 
components (water), and less permeable to other components, usually the contaminants that are 
found in the waste stream. The volume of water that accumulates in the permeate stream is 
quantified in terms of membrane flux, which is defined as the amount permeate flow produced 












  (1) 
 
Q represents the volumetric flow rate being fed into the membrane, and A represents the nominal 
surface area of the given membrane module.  
 
As mentioned previously, UF membranes were the primary focus of this research. These 
membranes have a tendency to retain colloids and substances with a high molecular weight. Ions 
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such as Mg2+ and Ca2+ will pass through the membrane pores, while almost all micro-organisms 
and polysaccharide-sized molecules will be retained. The pressure required to drive a UF 
membrane varies between 25 – 100 psi, depending on the specific application (Pontius, 1996). 
This operating pressure often plays a key role in deciding on what specific technological set-up 
will be implemented, as it represents a substantial cost in the overall scheme, mainly attributed to 
raising the pressure of large volumes of water. 
 
The pore size and/or the MWCO determine the separation capability of a membrane. Intuitively 
the smaller the pore size, the greater the capability for rejection that exists. Having said this, a 
smaller pore size will require a higher trans-membrane pressure, resulting in a larger operating 
cost. On average, the pore size on any given membrane module can vary up to 35-50 %, 
depending on the membrane material and age of the module (Takechi et al., 1998). It is 
important to note that the pore size of membrane modules are not constant throughout, and 
therefore there exist two distinct methods of classifying membrane pore size: an absolute pore 
size and a nominal pore size.  
 
An absolute pore size rating specifies the pore size at which a particle of a given size will be 
retained with 100 % efficiency under strictly defined test conditions. A nominal pore size rating 
describes the ability of the filter media to retain the majority of particulates (60 – 98 %) at the 
rated pore size. Process conditions such as operating pressure, concentration of contaminant, etc., 
have a significant effect on the retention efficiency of the filters (AWWA, 2005). 
 
Figure 2-3 shows the pore size distribution of all the membrane types, and also gives a few 




Figure 2-3: Pore size of filter medium and size of microbial particles 
Adapted from LeChevallier and Au (2004) 
 
As seen above, UF membranes have a pore size smaller than diatomaceous earth (DE) filtration 
pores, ranging between 10-8 to 10-6 meters in diameter. Although size exclusion is the primary 
mechanism by which contaminants in the feed stream are removed, it is not the only one and 
therefore pore size cannot be considered the only limiting factor in a UF membrane system. 
Differences in solubility and/diffusivity, and charge separation also play a role as exclusion 
mechanisms (MWH, 2005). 
 
Both low pressure membrane systems (MF and UF) remove particulate matter and turbidity as 
well as larger micro-organisms and viruses. Effluent turbidity values have been consistently 
reported to be lower than 0.1 NTU (Karimi et al., 1999). Another key feature of UF membranes 
is their ability to remove particulate metals such as iron and manganese, as MF membranes do 
not have this consistent capability (Gangloff, 2000). The removal of organic matter and more 
specifically humic substances by UF membranes is considered to be a challenge due to the 
associated organic fouling that occurs. Further discussion regarding this topic will be discussed 
in subsequent sections of this chapter. 
 
 13 
 Membrane structure and configuration 
The structure of a membrane refers to the way it is constructed to optimize surface area, and 
reduce the degree of fouling by incoming feed water. The most common types of structures are 
(Schäfer et al., 2005): 
 
• Spiral wound 
• Hollow fibre 
• Flat sheet 
• Tubular/capillary 
 
One of the more common structures for low-pressure membranes is the spiral wound 
configuration, as it allows for an optimal membrane surface given a very small working space. 
Figure 2-4 gives provides a summary of what the spiral wound module resembles, and highlights 




Figure 2-4: Spiral wound membrane module 
Schäfer et al., (2005) 
 
The raw feed water is fed axially through the membrane module at one end, and exits in parallel 
at the other end. As the name depicts, the module is essentially a flat sheet membrane that is 
wound into a spiral shape, ensuring that there is sufficient space between layers for the water to 
pass through. On this diagram, one can see that the membrane support is used to ensure sufficient 
space is provided between sheets. One of the primary reasons why these membrane 
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configurations are being used less frequently on a large scale is because of their tendency to 
irreversibly foul. Generally, these membranes cannot be back-flushed because of they way they 
are manufactured. The actual membrane modules are cast onto the interior support material, so 
any back-wash flow could potentially delaminate the membrane, exposing the inner surface. 
Because of this, these membranes rely heavily on chemical cleaning to remove any deposits from 
the membrane surface, representing a higher annual operating cost. 
  
Hollow fibre membranes have gained popularity in the last decade to become the most 
commonly used configuration in low pressure membrane filtration (MF or UF) for water 
treatment (MWH, 2005). These membranes usually consist of several hundred fibres encased in 
a module, whether it is full, pilot or bench scale. They are generally open tubes that are plug 
resistant and do not accumulate particles between the fibres. The internal fibre diameters are 
quite small to avoid fibre collapse when exposed to high pressure, range anywhere between 0.4 
to 1.5 mm (AWWA, 2005). These membranes can be exposed to frequent backwash cycles, 
which make them an attractive module type given that fouling is the primary limitation to the 
technology.  
 
Two types of flow regimes are used in practice, the first being the outside – in configuration, 
where the membrane is submerged in the feed water, and the untreated water is sucked in 
through the many porous fibres via a vacuum, and combined to become the permeate stream. 
The second configuration is the inside-out, where water is pumped into the membrane, and 
filtered through the fibres exiting into the surrounding water. The advantage of the second flow 
regime is that the water flows through a narrow channel, and therefore allows for good control 
over module hydrodynamics. Hollow fibre membranes offer a very high specific surface area to 
volume ratio, because of the small inner lumens of the fibres, and therefore have the ability to 
treat a larger volume of water.  
 
One of the major disadvantages to these membrane configurations is the fact that they are very 
susceptible to fouling, requiring frequent backwash cycles as compared to the spiral wound 
structures, which cannot be backwashed at all, and therefore are much more susceptible to 
fouling (Lee et al., 2004). An outside-in membrane will accumulate particles on the outside 
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surface of the membrane, making it not only easier to visually inspect the degree of fouling, but 
also much easier to backwash such a configuration. The inside-out configuration will accumulate 
particles on the interior of the membrane module, and represent a more challenging backwash 




Figure 2-5: Pressure-vessel configuration for hollow fibre membrane filtration 
Adapted from MWH (2005) 
 
As clearly seen, water enters at one end of the module, then gets filtered through the numerous 
fibres, combining to become the permeate stream.  The water that does not enter the fibres is also 
combined to become the retentate or concentrate stream. This brings up one of the few 
limitations to low pressure membrane systems that has not allowed for even further expansion of 
this technology. The concentrate stream that is generated must be disposed of accordingly, as it 
contains a very high concentration of targeted contaminant which is being removed by the 
membrane. The implementation of a concentrate disposal plan is crucial to an overall sound 
treatment system. 
 
There are four ways of disposing of these streams in North America: directly to a surface water 
source, domestic wastewater treatment plants, deep well injections and evaporation ponds. One 
of the key factor which determines which kind of disposal is implemented is the frequency and 
concentrations of chemicals used to clean the membrane modules. A concentrate that is relatively 
free of chemicals can generally be disposed of by discharging into large surface waters, while 
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concentrate streams that have been discharged from membranes exposed to high frequency 
chemical cleaning may have to be further treated, or simply disposed of in a landfill. Another key 
item to note is the difference that exists between low pressure membrane concentrate streams, as 
compared to high pressure systems like NF and RO membranes. High pressure systems often 
have high concentrations of dissolved solids and metal ions in the concentrate streams, which 
pose a threat to wildlife and habitats if disposed of directly into surface waters. Low pressure 
concentrate streams are mainly composed of organic matter and micro-organisms, which 
originate from surface waters, therefore their disposal is less worrisome (Marcel, 2004). 
 
Membrane material 
Membrane performance is influenced strongly by the physical and chemical properties of the 
material (MWH, 2005). As technology is evolving, membranes are being built with more 
sophisticated materials and with unique applications for the given source water. The most 
frequently used membrane materials in both municipal and industrial water treatment are 
polymer based: Cellulose acetate, acrylic, nylon, polypropylene (PP), polyamide (PA), 
polyamide-hydrazide (PAH), polyimide (PI) and polyethersulphone (PES). Ceramics and 
zirconia based materials have also gained popularity, but have not grown to be as popular as the 
polymer based modules. 
 
The most common polymer based materials are the PA’s, PAH’s and PI’s (Panglisch et al., 
2000). It is difficult to identify individual applications for each membrane material, as it can vary 
tremendously based on factors that are specific to any membrane system. Most consumer 
systems use cellulose acetate or nylon membrane materials wound in a tubular cartridge. In 
general, the cellulose acetate membranes are used with municipal water, which has been 
disinfected with chlorine, while nylon membranes are preferred in systems that use well water. A 
chlorine based city water supply requires a different membrane than rural "hard" water well 
based supply. The chemical chlorine will destroy the nylon membrane. (Gangloff, 2000). 
 
The polymeric materials will continue to prosper due to their flexibility, permeability and ability 
to be formed into a variety of filter components (Gangloff, 2000). However, specialty membrane 
materials, such as ceramic and composite constructions have the potential to experience rapid 
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growth, although on a much smaller scale, due to their higher unit cost and performance 
advantages in extreme environmental applications.  
 
Polymers are almost ideal membrane materials, since they can be easily produced with pores of 
almost any size and are flexible enough to be configured into a wide range of constructions, 
including flat sheets and hollow fibre cartridge materials (Klijn et al., 2000). However, there are 
several drawbacks to polymer membranes; the one that stands out most is the tendency toward 
fouling and clogging. This particularly can be the result of contamination from biological 
growth. Nevertheless, the advantages of polymers, coupled with the growing use of cross-flow 
designs, which minimize clogging by directing fluids toward the membrane at an angle, will 
ensure that for the vast majority of applications, polymers will remain the material of choice for 
years to come. 
 
Ceramics are another popular membrane material in the treatment of potable water. Ceramic 
membranes also have drawbacks. Chief among them are brittleness, increased size and higher 
cost on a square foot basis. These membrane types will remain limited to specific applications 
that require the performance characteristics offered by ceramics such as the thermal stability, 
abrasion resistance, durability and bacterial resistance. (Gangloff, 2000). Ceramics can also be 
placed in dry storage, as compared to polymer based membranes which have to be submerged in 
water to avoid damaging the material. 
 
However, new applications for ceramic membranes have been observed in the last decade; 
resulting in a more widely accepted usage, subsequently leading to above average growth 
(Bottino et al., 2001). Ceramics will also benefit from the growing trend toward composite 
membranes, which combine ceramic and polymeric membranes into a single system with the 
advantages of both types. In the end, the advances made to ceramic and composite membranes 







Membrane modules experience a great deal of wear and tear during the treatment of 
contaminated water. It is crucial to the life of a membrane that is well maintained and cleaned; 
otherwise it will have to be replaced, representing a substantial cost to the overall process. There 
are several ways that a membrane can be maintained in its best working order, mainly by pre-
treatment, air-sparging, backwashing and chemical cleaning. 
 
Pre-treatment of membranes has received a great deal of attention in the past decade as it is 
considered to have a great deal of potential in reducing the degree of fouling on the surface and 
inside the pores of membranes. This process entails exposing the incoming feed water to a 
different treatment method prior to the water entering the membrane module. As mentioned 
previously, research has been conducted using several pre-treatments, such as coagulation, bio-
filtration, advanced oxidation, pH adjustment, chlorination, activated carbon and other 
complexing agents (Kimura et al., 2005). Low pressure membranes have been used as pre-
treatment techniques for other technologies such as NF and RO system. Such is the case for the 
pre-treatment of seawater prior to RO, which has become a more common practice (Vial and 
Doussau, 2002). When using membranes, surface waters require more pre-treatment as compared 
to ground waters, as they have elevated TOC and turbidity concentrations.  
 
“The objective of backwashing is to remove the surface cake that develops during the membrane 
filtration cycle” (MWH, 2005). The term backwashing implies that the flow of water is reversed, 
and instead of raw water being pushed through the membrane, clean water is pushed in the 
opposite direction. Most low pressure membrane systems are set up with automatic backwash 
cycles, with frequency ranging between every 30-90 min (MWH, 2005). Backwashing targets 
the particles that have caused reversible fouling on the surface, flushing them away to increase 
permeate flux. Air sparging is another membrane cleaning technique that is generally used in 
combination with the backwash cycle. This process involves pumping a constant flow of 
pressurized air through the membrane module, which exits into the surrounding water in the 
form of gas bubbles. The objective of air sparging is to help scour material off the membrane 
surface, and in doing so reduce the amount of particles that remain on the membrane surface 
during the permeate cycle.  
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The backwashing coupled with the air sparging will be conducted based on a set point, such as 
time, or a key performance variable such as the rate of TMP increase over time. For example, a 
system could be set to permeate for 40 min and then conduct a backwash/air sparging cycle 
before returning to the filtration mode. It could also be set to conduct a backwash every other 
cycle, and air sparging every cycle. Some systems are set up trigger the backwash cycle once the 
TMP hits a specified maximum value. The backwash frequency is heavily dependent on the 
incoming water quality. A raw water with a high total suspended solids (TSS) concentration will 
required more frequent backwashes, as compared to a raw lake water which has lower TSS 
concentrations.  
 
Chemical cleaning is used to target the contaminants that cause irreversible fouling to the 
membrane. The frequency of chemical cleaning is different from that of backwashing, as it 
ranges from a few days to several months, depending on the membrane characteristics and 
source water quality. When foulants can no longer be removed from the membrane surface by 
backwashing, chemical cleaning is required. The procedure typically takes several hours and 
involves circulating preheated cleaning solutions throughout the membrane modules, draining 
the system several times and repeating. The large volumes of solution are often heated to 
temperatures up to 60oC, requiring a tremendous amount of energy, translating into a high cost 
(MWH, 2005). A variety of agents can be employed for the chemical cleaning of low pressure 
membranes: detergents, acids, bases, oxidizing agents, sequestering agents and enzymes 
(AWWA, 2005). Chlorine can also be used in doses ranging from 2 to 2000 mg/L; this in 
addition to acting as an oxidant capable of disinfection. 
 
It is difficult to accurately quantify the required chemical cleaning frequency of a given 
membrane system, as it is dependent on a number of factors, such as the concentrations of 
contaminants, volume of water treated, and required effluent quality. Van Paasen et al. (1998), 
compared the chemical cleaning frequency of surface water vs. ground water treatment plants, 
and concluded the membranes that treat groundwater require bi-annual chemical cleaning, while 
surface water require chemical cleaning 4-5 times a year. The following section provides detail 
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into the membrane fouling phenomenon, which will help tie together the reasoning for 
backwashing and chemical cleaning of a membrane. 
 
2.3 Membrane Fouling 
2.3.1 Introduction 
The main limitation to the use of membranes in drinking water treatment is its high energy 
consumption that can mainly be attributed to membrane fouling, which causes the applied 
pumping action to work harder to maintain a constant flux (Kimura et al., 2005). Membrane 
fouling is the process by which the permeate flux through the membrane is reduced as a result of 
particles accumulating on the surface, forming a cake layer, or the adsorption of particles (both 
suspended particles and dissolved material) inside the membrane pores (AWWA, 2005). 
Membrane fouling can be divided into two types: reversible and irreversible fouling. As 
previously mentioned, reversible fouling can be restored by backwash cycles, while irreversible 
fouling requires chemical cleaning to be mitigated. There are four major types of fouling 
mechanisms that affect drinking water membranes: 
 
• Organic fouling 
• Bio-fouling 
• Scaling 
• Colloidal/Particulate fouling 
 
Organic fouling is caused by both dissolved and suspended particles that adsorb inside the pores 
and on the surface of the membrane. There are several factors already discussed that have the 
potential to influence organic fouling caused by NOM, although there are three primary ones: 
MW distribution, the membrane surface and chemical composition of the feed water. 
 
Bio-fouling is the growth of living micro-organisms on the surface or inside the pores of a 
membrane. The living organisms use the membrane as a support, and in doing so reduce the 
permeate flux and cause fouling. It has been shown that chlorine dioxide removes bio-film from 
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water systems and prevents biological growth from forming when dosed at a continuous low 
level. Hypochlorite on the other hand has been proven to have little effect on bio-films (Soffer et 
al., 2005). 
 
Membrane scaling is a consequence of a given water source’s solids concentration exceeding its 
solubility limit, resulting in precipitation of solids on the membrane. This occurs when the 
concentration of the given species is too high at the membrane surface, causing it to come out of 
solution and deposit onto the membrane surface. Precipitated inorganic compounds can act as 
scalants which can reduce the flux, can damage the membrane surface and cause irreversible 
pore blocking. When particles block membrane pores, the higher dissolved molecule 
concentration yields higher osmotic pressure, higher tendency of suspended solids to coagulate 
and coat the membrane surface, and higher likelihood of pore plugging (scaling) to occur 
(AWWA, 2005). 
  
Colloidal and particulate fouling is a fouling mechanism in which the particles accumulate on the 
membrane surface or inside the pores, resulting in reduction of the permeate flux. Colloidal 
surface charge is related to the zeta potential of given membrane. Zeta potential is the electrical 
potential that exists at the shear plane of a particle, which is some microscopic distance from the 
surface (AWWA, 2005). Zeta potential influences the porosity of the cake formation and the 
hydraulic resistance.  
 
The overall fouling mechanism can be described using the Resistance in Series Model (RSM) 
(Schäfer et al., 2005). There are four primary components of resistance that contribute to 
membrane fouling: resistance due to the intrinsic membrane (Rm), resistance due to cake 
formation (Rc), resistance due to internal pore fouling (Rpb) and resistance due to adsorption (Ra). 
Figure 2.6 shows how the four resistance mechanisms combine together to form an overall 




Figure 2.6: Membrane resistance mechanisms 
Adapted from Schäfer et al., 2005 
 
Fouling has received a great deal of attention from water treatment research experts, as many 
situations show that there is no clear distinction as to whether it is the dissolved or suspended 
particles that contribute to fouling most. Howe and Clark (2002a) concluded that the most 
significant membrane fouling occurs in the presence of small colloidal matter, ranging from 
about 3-20 nm in diameter. Their findings demonstrate that the majority of dissolved organic 
matter (DOM) by itself does not cause membrane fouling, but rather the actual foulant is a 
relatively small fraction of bulk DOM. Combe et al. (1999) found that NOM adsorbs both inside 
pores and on the membrane surface, forming a gel layer, which thickens over time reducing the 
overall flux across the membrane surface. 
 
Fouling is the aspect of low pressure membrane systems that is receiving the most attention in 
water research today. It represents a very large fraction of the annual cost for a membrane 
system, as it substantially increases the cost of a process by increasing energy requirements and 
replacement frequency. One of the least understood aspects of fouling is how NOM affects 
membrane surfaces. Although a great deal of research has been conducted using NOM, it is only 
recently that some success has been achieved in understanding what portion of the NOM 
contributes to fouling most. Because of the importance of NOM for fouling, it is discussed in 
more detail in the next section. 
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2.3.2 The Origin of Natural Organic Matter 
One of the important group of substances that exist in Canadian surface and ground waters today 
is NOM, found in concentrations ranging from 1 to 15 mg/L, depending on the season and 
specific location (AWWA, 2005). Groundwater sources in North America tend to have less than 
2 mg/L TOC, while rivers tend to have a slightly more elevated level ranging from 3-6 mg/L. 
 
Natural organic matter (NOM) is primarily made up of humic substances, which are poly-
phenolic molecules that give rise to yellow-brown water that is aesthetically undesirable. The 
NOM also has the potential to combine with disinfection compounds such as chlorine, to form 
such disinfection by-products (DBP) as organo-chlorines (Maartens et al., 1999). These by-
products have been proven to act as carcinogens in bench-scale animal studies (Singer, 1999). 
The potential for NOM to complex with metals also exists, and as a result, can potentially 
increase metal solubility, having direct adverse effects on human health (Jones and Bryan, 1998). 
 
Humic substances are a major component of suspended and dissolved NOM in aquatic 
environments. They are mainly derived from soil and are also produced within natural water and 
sediments by chemical and biological processes such as the decomposition of vegetation 
(AWWA, 1999). A major component of NOM found in natural waters are humic substances.  
Humics are anionic poly-electrolytes of low to moderate molecular weight, ranging between 
2000-5000 Da, dominated by phenol groups. The negative charge is caused by the carboxyl and 
phenolic groups that make up the structure of the compound. They have both aromatic and 
aliphatic components, allowing them to be surface active, which is the ability of a compound to 
lower the surface tension of a given medium in which it is dissolved (Kokkola et al., 2006). In 
addition to humic substances, proteins, polysaccharides, and other classes of biopolymers also 
contribute to NOM in natural waters. Monomeric species such as simple sugars and amino acids 
are also present in natural water sources, but they are much less abundant, as they are subject to 





This thesis targeted organic carbon in the form of humic acid as a simulator for NOM in true 
aquatic environments for synthetic water sources, as well NOM found in raw water sources 
found in Southern Ontario. The name NOM implies that it is of natural origin, but as a practical 
matter the molecules collected as NOM from any water source can include many organic 
compounds contributed by human activities (AWWA, 2005). 
 
2.3.3 Fractionation as a fouling prediction aid 
Fractionation of a given water sample into a series of molecular weight cut offs serves as a useful 
method in predicting  what fractions were coagulated and potentially which contribute d to the 
fouling severity of a membrane. Howe and Clark (2002a) performed a series of rigorous 
experiments to further the understanding of NOM fouling potential. Raw lake water was 
subjected to a three step sequential filtration process: pre-filtration, fractionation and fouling 
determination. The raw water was first pre-filtered through a 0.45 µm filter to remove any 
particulate matter. Aliquots of the filtrate were put through regenerated cellulose (RC) 
membranes with nominal MWCO’s of 3000, 10000, 30000 and 100000 Da, keeping one of the 
aliquots un-fractionated. By removing any suspended particulates in the pre-filtration stage, the 
surface cake formation was minimized, and alternate mechanisms of fouling were easier to 
observe. Each of the fractionated waters was filtered through a 0.2 µm polypropylene membrane 
and the flux was monitored to determine the fouling caused by each aliquot. 
 
The conclusions that came from these series of experiments were not consistent, as results 
showed that the mid-sized dissolved particles contributed to 65 % of the fouling, while a second 
trial with a different source water showed different results. In the first trial, the material that 
passed through the 100,000 Da membrane contributed to 50 % of the fouling, while in the second 
trial, over 75 % of the fouling was due to material smaller than 100,000 Da. Colloids that were 
able to pass through a 100,000 Da membrane corresponded to a colloidal size smaller than 
approximately 0.02 µm. Having said this, this study supported the notion that fouling is not 
directly proportional to the TOC level in water, but rather the MW distribution of the NOM and 
their corresponding concentration that have a larger impact on the severity of fouling. 
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2.4 Membrane Performance and Fouling by NOM 
An understanding of NOM as a membrane foulant and the behavior of NOM components in low-
pressure membrane fouling are needed to provide a basis for appropriate selection and operation 
of membrane technology for drinking water treatment (Lee et al., 2004). Removal of humics by 
low pressure membrane filtration has in the past been considered challenging because of the 
strong effect that is induced by organic fouling that occurs on the surface and inside the pores of 
the membrane surface. In general, the fraction of humic substances removed by membrane 
filtration depends heavily on the type of membrane used, and the chemistry of the raw water 
(Ruohomaki, 1999). Several authors (Lin et al., 2000 and Domany et al., 2002) have attempted to 
quantify the removal of humics by membrane filtration. Lin et al. (2000) observed a removal of 
10 % of Aldrich humic acid using a 100 kDa membrane module. This membrane was operated at 
an initial flow of 330 L/m2h (LMH), reducing to approximately 198 LMH in 25 hours of 
operation, representing a decrease in flux of 40 %. Domany et al., (2002) performed a similar 
study, using 100 kDa membrane modules with an initial flux of 200 LMH. Comparatively, there 
was a 65 % removal of the Aldrich humic acid observed. In both cases, hydrophobic membranes 
were used, although their material varied slightly.  The first study made use of polysulfone 
membranes, while the second study utilized PES membranes, with a TMP approximately 20 % 
lower. Although many studies have been performed in an attempt to understand the fouling 
potential of NOM, still much remains to be learned because of the complexity of its physical 
state (Maartens et al., 1999).  
 
A hydrophobic component is defined as having a surface that is repelled away from a water 
surface, while a hydrophilic fraction has the opposite property of having the ability to be 
attracted to water based surfaces. Many researchers have suggested that the humic fraction of 
NOM is a major foulant which controls the extent of fouling (Combe et al., 1999; Jones and 
O’Melia, 2000). On the other hand, other studies have reported that hydrophobic (non humic) 
fractions might be a more significant foulant (Carroll et al., 2000). Fan et al., (2001) identified 
potential foulants in order as hydrophilic neutrals > hydrophobic acids > transphilic acids.  
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Lee et al., (2004) concluded that natural waters with a high content of hydrophilic organic 
material resulted in more significant flux decline. This was primarily attributed to the fraction 
containing colloidal and macromolecular organic matter with non-humic properties. He further 
concluded that distinct differences in flux decline between hydrophobic and hydrophilic 
membranes were not observed suggesting that other membrane properties may play a larger part 
in the fouling process. The shape and size of molecules and roughness of the membrane surface 
were presumably more important factors in affecting flux decline. 
 
2.5 Background on Coagulation 
Coagulation and flocculation is defined as the process by which small particles in aqueous 
solution destabilize because by chemical addition, and aggregate together, forming larger 
particles known as flocs. With a neutral suspension, the flocculation rate can be enhanced, and 
the concentration of the given particle distribution in the solution can be reduced (AWWA, 
1999). The coagulation process is a complicated one, with many mass transfers and active 
species that take part in the reaction steps. The process can be broken down into three key steps: 
Coagulant formation, particle destabilization (coagulation) and inter-particle collisions 
(flocculation). Enhanced coagulation, often referred as ‘low pH coagulation’ is often used to 
increase the removal of TOC and other particles. This is accomplished by reducing the raw water 
pH to an optimal level: a pH in the range of 4.5-5.5 for iron based coagulants and 5.5-6.5 for 
aluminum based coagulants (Sharp et al., 2006). In order to understand the mechanism by which 
coagulants function, one needs to be familiar with the exact type and their form. 
 
This thesis involved the usage of five coagulants: ferric chloride, aluminum sulphate (alum), and 
three polyaluminum chloride (PACl) coagulants: SternPac, SternPac 70 and SternPac 2300. 
Ferric chloride and alum are two widely used coagulants both in the drinking and waste water 
industries. They are known as hydrolyzing metal salt (HMS) coagulants with the active metal 
being Al3+ and Fe3+ for alum and ferric chloride respectively (AWWA, 1999). In solution, these 
small, positively charged ions form a strong bond with oxygen atoms of six surrounding water 
molecules, e.g., M(H2O)6
3+, with the M representing the active metal. The hydrogen-oxygen 
bond is subsequently weakened, and the hydrogen ions are released into solution. This reaction is 
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known as hydrolysis, and the resulting active metal hydroxide species are known as hydrolysis 
products. The process is a progressive de-protonation of water molecules in the primary 
hydration shell (Richens, 1997). Hydrolysis of such ions is generally represented as a sequential 
replacement of the water molecules by hydroxyl ions (Gregory and Duan, 2001). The simplest 
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Each step involves the loss of a proton, with an increase in pH causing the equilibrium to shift to 
the right. Aluminum hydroxide (Al(OH)3) has a very low solubility in water, with precipitation 
occurring at intermediate pH values. One must consider the solubility of the metal hydroxide 
precipitate to maximize performance and minimize residual metals in solution during the 
coagulation process. At low pH values (below 5.0), the dissolution of the precipitate produces 
positively charged soluble hydrolysis products and the (aquo) ion. At high pH values, 
(aluminate) ions are formed (above 7.8). At a pH of 6.5, the precipitated Al(OH)3 is least soluble, 
therefore optimizing the coagulation process by incorporating the maximum amount of Al in 
particulate form. This pH of minimum solubility is also a function of temperature, with the pH 
increasing slightly with decreasing temperature (AWWA, 1999).  
 
As well as the simple monomeric hydrolysis products considered above, the highly charged Al 
ions can form a variety of polynuclear species: these include Al2(OH)2
4+ and Al3(OH)
4+. Various 
polymeric species, such as Al6(OH)12
6+, have been proposed, but their existence has not been 
convincingly demonstrated. They might be regarded as intermediate forms in the conversion of 
soluble metal salts to solid precipitates. It is known that hydrolysis precipitation processes at 
ordinary temperatures are very slow and that true equilibrium can take months or years to 
achieve. One polynuclear hydrolysis product of aluminium is now well established. This is the 
so-called “Al13” polymer, Al13O4(OH)24
7+, which can be formed by controlled neutralization of 
aluminum salt solutions (Gregory and Duan, 2001). 
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The two main ways in which hydrolyzing coagulants act to remove particles are charge 
neutralization and sweep flocculation. Charge neutralization is a reasonably simple mechanism, 
which involves the specific adsorption of the cationic hydrolysis products from solution onto the 
negatively charged particles. NOM and other particles can be destabilized by small amounts of 
hydrolyzing coagulant. Desirable destabilization corresponds with the neutralization of particle 
charge, which then leads to aggregation of the neutral particles (Gregory and Duan, 2001). It is 
important to note that larger amounts of the positively charged coagulants (over dosing) can 
cause charge reversal, leaving the particles positively charged and thus re-stabilized. When 
charge neutralization is the dominant mechanism, the coagulant dose is generally considered to 
be proportional to the concentration of particles in solution, although in some cases, required 
doses can still be dominated by the type of NOM found in the water, and not simply the 
concentration. 
 
In some cases it is found that a higher coagulant dose is more effective, due to extensive 
hydroxide precipitation and the process known as sweep flocculation (Jiang, 2001). Sweep 
flocculation can overcome two of the primary disadvantages of destabilization by charge 
neutralization: The first being the fact that very accurate control of the coagulant dose is required 
to give optimum destabilization, and the second is the fact that the coagulation rate depends on 
the particle concentration, and can therefore be extremely low for dilute solutions. Sweep 
flocculation avoids both of these problems by using much higher doses, forming larger quantities 
of amorphous hydroxide precipitates. The target particles are enmeshed in this growing 
precipitate, and then can be removed by sedimentation, giving the term “sweep floc”. Sweep floc 
is the mechanism that takes place when the water pH is above the zero point of charge for the 
dissolved species formed from the coagulants such as alum. 
 
When HMS’s are added to water, hydrolysis reactions produce hydrogen ions that react with 
alkalinity species in solution. If the hydrolysis reactions are promoted by addition of a base 
during manufacturing, the resulting product is a pre-hydrolyzed metal salt coagulant solution. 
Pre-hydrolyzed coagulants are generally classified in terms of basicity, which is the extent of 
hydrolysis reactions that were induced during the manufacturing of the coagulant. The following 
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“Where, [OH] / [M] is a weighted average of the molar ratio of the bound hydroxide to metal ion 
for all the metal hydrolysis products in the undiluted coagulant solution.” (AWWA 1999). 
Basicity values range between 10-75 %. Values above 75 % make it very difficult to keep the 
metal hydroxide precipitate from forming in the product solution during storage and shipping. 
The pre-hydrolyzed coagulants used in this project are formed by the controlled neutralization of 
aluminum chloride solution, and are generally known as poly-aluminum chloride (PACl). SP 70 
and SP 2300 are coagulants produced by Eaglebrook, Inc. (Matteson, IL), with basicity levels of 
70 % and 65 % respectively. As compared to the well known alum and ferric chloride, there is 
much less literature concerning the usage of these coagulants for pre-treatment for membrane 
filtration. One important point to note is the fact that PACl products already contain some of the 
polynuclear species of aluminum, which are materials that are very effective at the modification 
of colloidal charges in water treatment applications. It has also been shown that PACl products 
give more rapid flocculation and stronger flocs than alum for equivalent dosages. These 
improved results were found under conditions of elevated TOC (above 6 mg/L) concentrations 
and pH values between 5.5 and 6.5. (Jiang, 2001). 
 
Gregory and Dupont (2001) found pre-hydrolyzed coagulants to be advantageous over HMS 
coagulants. Specifically, the authors found benefits of PACl over alum for uses in drinking water 
treatment applications. These include improved performance at low temperatures, lower 
aluminum residuals in treated water and significantly reduced sludge volumes. It was also shown 
that flocs formed with some commercial PACl products are larger, stronger and are more readily 
separated than those with alum. However, there are several common features, notably the fact 
that floc volume increases in proportion to coagulant dosage in all cases.  
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2.6 Coagulation Performance 
Although coagulation history goes back three thousand years, the modern use of coagulants for 
water treatment started approximately 100 years ago, when aluminum sulphate and ferric 
chloride were used as coagulants in full scale water treatment. Since the 1980’s, the optimization 
of coagulation performance for the removal of NOM has been systematically studied, using 
various real surface and synthetic waters (Jiang, 2001). In the 1990’s, NOM and other precursors 
of the disinfection by-products were still a primary cause for concern. Prior to that, the focus of 
coagulation was for particle removal, which has been addressed in the previous section. 
2.6.1 NOM removal by coagulation 
The removal of organic contaminants by the coagulation process has been studied for decades. 
Most of the work shows that coagulation substantially reduces the concentration of organic 
particles; a primary type being components of NOM (Randtke, 1988). It is difficult to predict the 
percentage removal of NOM from surface waters with coagulation, as it depends on a variety of 
conditions such as organic matter characteristics and operating conditions. Removal of 
particulate NOM is achieved primarily through colloidal destabilization, followed by 
sedimentation and filtration (Randtke, 1988). NOM is traditionally removed by coagulation with 
the trivalent Al and/or Fe metal ions. The coagulation mechanisms that are thought to dominate 
with regards to NOM removal are charge neutralization for colloidal material and charge 
complexation for soluble compounds (Sharp et al., 2006). 
 
In general, the process is maximized under similar conditions that also provide maximum 
turbidity removal, although maximum turbidity removal can also be achieved over a broader 
range of conditions. This occurs under acidic conditions with a pH in the range of 4.5-5.5 for 
iron based coagulants and 5.5-6.5 for aluminum based coagulants (Sharp et al., 2006). Dissolved 
NOM removals by coagulation ranged between 10 and 90 %, with an average removal of about 
30 %. Greater removals were seen when more highly colored waters containing organic matter of 
higher molecular weight were being treated with a metal coagulant. 
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 In summary, it was concluded that there was not a substantial difference between aluminum and 
iron based salts. 
 
The coagulant dose plays a very important role in the removal of NOM, generally following one 
of two patterns. In the one case, the removal increases very quickly within a given range of 
coagulant dose, and then the concentration stabilizes after that. The second pattern showed that 
the concentration decreases very gradually, eventually reaching an optimum removal at a much 
higher concentration than that for the first behavior type (Randtke, 1988).  
 
Several other experimentally based research projects have been undertaken, yielding several 
conclusions that helped to further the understanding of what effect coagulation has on the 
removal of NOM in any given source water. The use of specific ultraviolet absorbance (SUVA) 
as an indicator of the nature of the NOM and the effectiveness of the coagulation process has 
been explored very thoroughly (Edzwald et al., 1999). SUVA is defined as the normalized UV 
absorbance of a water sample with respect to the DOC concentration. It is expressed in units of 
m-1 of absorbance per mg/L of DOC (Weishaar et al., 2003). 
 
The humics based portion of the NOM was characterized based on the corresponding SUVA 
values. Waters with high concentrations of aquatic humics generally have high SUVA values, 
rising as high as 6-7 L/mg.m). Removal of 50 % or greater is expected for such waters using 
aluminum based coagulants such as alum or PACl. As the SUVA value of a given water source 
decreases, so should the removal capacity of the coagulant. Waters that display a SUVA value 
less than 3.0 generally correspond to removals of less than 30 % (Weishaar et al., 2003). 
 
2.7   Background on the use of Pre-coagulation of NOM to Low 
Pressure Membrane Systems 
When the drinking water industry began to utilize membrane filtration, the water sources being 
treated with membranes were generally high quality, low turbidity lakes that required minimal 
treatment (Howe and Clark, 2006). Membranes were able to stand alone, and provide high 
quality effluent, without the need to integrate other treatment processes. With the high level of 
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success, membrane treatment processes are being implemented for lower quality water sources 
that required more extensive treatment, and as a result coagulation pre-treatment for membrane 
filtration is now becoming more common. 
 
The results obtained from research evaluating coagulation as a pre-treatment to low pressure 
membrane filtration has been inconsistent in quantifying its effects on fouling and flux decline. 
Several studies have shown improved membrane performance, while others have shown 
decreased membrane performance. Several studies have shown that the use of coagulation has 
the potential to either stabilize or improve permeate flux across the membrane surface, while 
others have shown that the coagulant addition contributes further to the undesirable fouling 
phenomenon. 
 
Howe and Clark (2006) conducted a study to further understand the effect of pre-coagulation. 
Their primary objective was to evaluate the effect of coagulant type, its dose, and application 
conditions on membrane performance. Five different natural surface waters were used, coupled 
with three different membrane materials. After all of the results were combined, it was concluded 
that coagulant dose was the most significant factor in determining the severity of fouling, and in 
turn whether the membrane performance was better or worse. At low doses, the membrane 
fouling was worse when compared with no coagulant. These doses were generally coupled with 
minimal floc formation.  
 
Enhanced coagulation has been implemented in pre-treatment research by several authors. As 
previously mentioned, it is the removal of NOM under conditions of high coagulant dosages, 
combined with a low pH in the range of 4-6 (AWWA, 2005). It is important to note that elevated 
coagulant doses will contribute to a reduced pH level. Alum consumes 0.5 mg/L of alkalinity as 
CaCO3 for each mg/L of alum; each mg/L of ferric chloride consumes 0.93 mg/L of alkalinity as 
CaCO3. If the dose of alum and/or ferric chloride is increased beyond the available alkalinity it 
could result in a small concentration of coagulant passing through the treatment process. This 
occurs because the alkalinity helps to limit the reduction in pH and once it is consumed the lower 
pH may lead to an increased concentration of dissolved metal than can move downstream to the 
next treatment stage. When a dose that induces enhanced coagulation was used, the membrane 
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performance was also improved for all coagulants. The third major conclusion that came out of 
this research was the fact that there exists a linear relationship between the quantity of DOC 
removed and the increased membrane performance. This conclusion was independent of 
coagulant type, as whichever one was most effective at removing DOC in a given water source 
was also most efficient at improving membrane fouling. 
 
Maartens et al. (1999) studied the reduction in fouling of polysulphone UF membranes used for 
the purification of natural brown water, collected from Suurbraak, in the Southern Cape of South 
Africa. The raw water was pre-treated by coagulation and by changing the pH of the feed 
solution. The research showed that the pH of the feed water has a significant influence on the 
adsorption of NOM onto the membrane surface. The lowest adsorption occurred at a feed water 
pH of 7. At this pH level, NOM molecules contained equal amounts of COO- and COOH groups 
(quantified using a non-aqueous titration method) resulting in a very stable conformation of 
NOM which lowered the interactive forces between the membrane surface and the foulant 
molecules. The UF membrane yielded the best performance at this pH value in terms of permeate 
flux, colour rejection and foulant adsorption. Direct filtration eliminates the use of a flocculation 
tank, coupled with a reduced coagulant dose. The raw water develops pinpoint flocs while 
traveling towards the membrane surface, much smaller than the conventional floc formation that 
occurs in a flocculation tank. Direct filtration treatment of the raw water with the metal ion 
coagulants decreased overall system performance, by increasing the rate at which the membrane 
fouled, and increasing the frequency of backwash and chemical cleaning. Therefore it was 
concluded that no obvious advantages were obtained by this pre-treatment method. 
 
Kabsch-Korbutowicz (2006) studied the pre-coagulation of natural water flowing from the Great 
Batorow Peatbag River in Poland, followed by membrane filtration using polyethersulphone and 
regenerated cellulose UF membranes. Pre-coagulation of the feed water with aluminum based 
coagulants improved the elimination of NOM substances by approximately 15-20 %. The highest 
removals were observed when PACl products were used, with values ranging between 20-25 % 
improvement over experiments completed without the pre-coagulation. The highest membrane 
permeability was observed when alum was used. More importantly, the NOM removal and 
fouling results were proportional, and therefore the system could be optimized to meet the 
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requirements of both system components. The coagulant dose had a significant impact on the 
permeate flux of the membranes as well. At low Al doses that would normally not be used if 
coagulation was the sole treatment process, membrane fouling was higher in comparison to water 
that was not exposed to any pre-treatment step. Laine et al. (1999) performed similar 
experiments with regenerated cellulose membranes, discovering elevated concentrations of PACl 
products yielded a more consistent flux across the membrane surface, and in turn reduced the 
degree of fouling that occurred. 
 
Kimura et al. (2005) studied the use of pre-coagulation with sedimentation as a pre-treatment to 
pilot scale polysulfone UF plant at an existing drinking water treatment facility in Ebetsu, Japan. 
The effect of metal based pre-coagulation on irreversible membrane fouling was studied and 
compared to a previous study performed (Kimura et al., 2004) where a similar type of membrane 
effluent was used as a drinking water source.  
 
The study performed in 2004 investigated the water permeability consistency using a chemical 
cleaning process, and analyzed the composition of the membrane fouling components that 
desorbed from the membrane after the cleaning cycle. The study concluded that polysaccharide-
like organic compounds were primarily responsible for the inducement of irreversible fouling. 
The results observed using this raw water source, supported the fact that pre-coagulation in some 
cases would not be effective in mitigating irreversible fouling, as coagulation does not target 
polysaccharides efficiently. The second study incorporated coagulation, showing very positive 
results. The pre-treatment significantly mitigated the organic membrane fouling, mainly by 
reducing the concentration of components that had the potential to cause reversible fouling, 
which was largely composed of DOM. The study did re-emphasize that irreversible fouling 
cannot be mitigated with the use of coagulation as pre-treatment to UF membranes (Kimura et 
al., 2005). 
 
Several other authors have suggested that coagulation, whether it is with sedimentation or direct 
filtration (i.e. without sedimentation), induced membrane fouling. Shrive et al., (1999) performed 
a pilot scale membrane trial using water taken from the Ohio River with polypropylene micro-
filtration membranes. The purpose of these experiments was to assess the degree of fouling of 
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the membrane when exposed to a water source that was purposely under dosed (1-5mg/L) with 
alum or PACl. The experiments were performed with sedimentation and in-line coagulation to 
observe the difference it made on the membrane fouling as well. A large decrease in flux was 
observed for all coagulants during the in-line coagulation as a pre-treatment, while much less of 
a decline was observed when coagulation was coupled with sedimentation.  
 
Karimi et al. (1999) observed very similar results when pre-treating feed water to a 
polypropylene ultra-filtration membrane with 3-5 mg/L of ferric chloride. The treated surface 
water taken from the Californian interior accelerated the rate of fouling, as observed by 
increasing trans-membrane pressure. In some cases, the use of a coagulation pre-treatment 
process not only accelerates the rate of fouling, but also substantially increases the cost of the 
overall system, in some cases making it prohibitive to implement. Schäfer et al., (2001) 
concluded in a polypropylene membrane study that pre-treating water containing Suwannee 
River humic and fulvic acid solutions with ferric chloride significantly increased fouling of 
micro and ultra-filtration pilot scale membranes. The coagulant dose would also increase the 
operating cost of the system, emphasizing that the correct dose is crucial to both the efficiency of 
the system and the overall cost. 
 
In some cases, the results achieved through the study of coagulation pre-treatment were not so 
much inconclusive, but more so the fact that similar results could have been achieved with a 
simpler process. Carroll et al. (2000) found that pre-treating water prior to micro-filtration using 
a polypropylene membrane with 35 mg/L of alum reduced the quantity of reversible fouling by a 
substantial amount. Moreover, it was discovered that similar results could be achieved by 
filtering the feed water through a 0.2 µm filter, in doing so removing the particulates that were 
contained in the water. This comparative worked highlighted the fact that the coagulation in this 
case was successful at removing particulate foulants, but had no noticeable effect on the 
dissolved material. Comparing these findings to those of Howe and Clark (2006), several 
contrasts were observed. The latter work concluded that coagulant dose was the most important 
factor in quantifying fouling, rather than the state of composition of the TOC in the feed water. 
Maartens et al. (1999) stated that certain types of fouling cannot be mitigated at all with 
coagulation pre-treatment, and therefore attention should be focused on other aspects of the 
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experimental design, in hopes of reducing membrane fouling. However, it is worth noting that 
Howe and Clark (2006) emphasized that an enhanced coagulation process (reduced pH) will 
yield improved permeate flux, and should be used as a base-lime for future coagulation pre-
treatment experiments. 
 
2.8 The Future of Low Pressure Membrane Systems 
Membrane technology for drinking water applications has the potential to be the most promising 
development in water treatment, as it could provide permeate quality that exceeds the present 
regulatory requirements for drinking water consumption (Farahbakhsh et al., 2004). The 
technology itself will gain more popularity and research-driven membrane trials will yield more 
efficient full-scale systems that require less energy input, coupled with membrane modules that 
have extended life expectancies. (Zularisam et al., 2006). 
 
There are still a variety of problems that limit the expansion of membrane technology: the 
primary one being the fouling phenomenon. In the 21st century, further understanding is required 
into what fractions of NOM contribute to fouling most, and one can improve process design and 
operating conditions to minimize this effect. Just as important are issues such as membrane 
surface area and robustness, the cost of the operation and maintenance associated with the 
required high trans-membrane pressure, and the cost of chemicals required to clean the 
membranes. However, these problems should not be considered a downfall to the further 
advancement of the technology, but rather as reasons to come up with methods of improvement 
and optimization. Zularisam et al. (2006) stresses that there is need for further research and 
development of new membrane materials that are more resistant to both chemical cleaning and 
mechanical wear and tear. The improvement of cleaning strategies and reduced energy costs will 
help to increase implementation and improve sustainability of membrane systems.  
 
Experts most familiar with membrane filtration processes predict that future low pressure 
membrane systems will be larger in capacity with smaller footprints, therefore increasing the 
available surface area, while reducing the overall space requirement. One way in which 
membrane treatment technologies will be improved in the future, is by integrating them with 
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other processes such as a coagulation pre-treatment. Government guidelines and regulations 
governing the use of membrane filtration are expected to expand, and become more 
standardized, so that researchers, manufacturers and plant operators alike can be on the same 
page with respect to the implementation of techniques for reducing membrane fouling. The 
applicability of these systems is also expected to expand, as studies have proved in many cases 
that membrane systems are the preferred option for pathogen and particulate removal. 
 
2.9 Research Needs 
This literature review provided a lot of detail pertaining to the fundamentals of coagulation,  and 
membrane filtration. Although the topic of study is growing every year, there was less detail 
concerning the combination of the two, and more specifically how the modification of different 
parameters affect water quality and membrane fouling. There was definitely a gap in literature 
concerning NOM fractionation, and the effect that each of the size distributions had on 
membrane performance, and downstream operations.  
 
Another aspect of this research which was not thoroughly discussed in this chapter was how the 
different membrane properties such as zeta potential, contact angle and surface charge contribute 




CHAPTER 3  
 
EXPERIMENTAL PLAN AND MATERIALS AND METHODS 
3.1 Experimental Plan 
The purpose of this research was to quantify the effect of coagulation pre-treatment on the 
performance of a submerged ultra filtration membrane system. Initially, a series of experiments 
were conducted with synthetic waters, with known concentrations of humic acid in order to gain 
an understanding of how the coagulants would behave. The synthetic waters were prepared to 
cover the range of major characteristics in the two raw waters chosen for study. Subsequently, 
experiments were carried out with the two different raw waters. The goal of the work was to gain 
a more fundamental understanding of effects the coagulants have on the fouling potential of a 
membrane, and their ability to remove TOC and turbidity. All measured standard water quality 
parameters were regularly assessed to ensure continuity across all membrane trials. Fractionation 
of both raw and treated water samples into a series of molecular weight cut-offs (MWCO) was 
conducted. This was an innovative approach, in terms of coagulation pre-treatment experiments, 
and was done to further understand what portions of the NOM contribute to fouling most. 
 
There were two distinct phases: The coagulation of raw and synthetic waters to determine 
optimal coagulation dosages, and the treatment of two different raw surface waters with a bench-




3.2 Source Water Details 
This project involved the study of two different Ontario surface waters. The first was water taken 
from the Grand River, which is the source water for the Mannheim Treatment Plant in Kitchener, 
ON. The second was water taken from Lake Ontario, which is the source water for the 
Woodward Water Treatment Plant in Hamilton, ON. Water quality data recorded daily at the 
plant intakes for the year 2004 were acquired from the Ontario MOE Drinking Water 
Surveillance Program (DWSP, 2005). Although these two source waters exhibit many different 
characteristics, the project focused primarily on using only four key parameters to characterize 
the two different waters: turbidity, total organic carbon (dissolved and suspended), pH and 
alkalinity. 
3.2.1 Grand River Watershed 
The Kitchener (Mannheim) Water Treatment Plant, operated by the Regional Municipality of 
Waterloo, treats water from the Grand River. The Grand River flows 300 km through south-
western Ontario from the highlands of Dufferin County to Port Maitland on Lake Erie (GRCA, 
2005), draining a predominantly agricultural watershed. Raw water is pumped approximately 10 
km from the Grand River to the Mannheim WTP. The process consists of disinfection, 
coagulation, flocculation, sedimentation, ozone, bio-filtration and UV. In 2002, the filtration 
stage was either a dual media filter, or granular activated carbon (GAC) filters, depending on 
seasonal water quality variations. The facility was commissioned in 1992, and presently has a 
design capacity of 80,000 m3/day. 
 
All of the raw Grand River water used in this research was obtained from the Mannheim plant’s 
Hidden Valley intake. Water was transported from the intake to the laboratory at the University 
of Waterloo in 25 L Nalgene containers. The raw water was used within 72 h of collection. 
 
Water quality parameters values in the Grand River are highly variable throughout the year. This 
variability is likely due to a combination of agricultural, urban and industrial inputs and seasonal 
impacts such as elevated precipitation and/or drought (GRCA, 2006). 
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The fluctuations in acidity in the river over a given year are the result of vegetation processes in 
the river. Limestone bedrock found throughout the Grand River watershed buffers the acidity of 
the water and tends to cause river water to be more basic, rather than acidic. The average pH 
level for the month of June, 2005, was approximately 8.4, while in March, 2005 the level 
dropped to 7.7 (less plant activity). This data was collected by the Drinking Water Surveillance 
Program (DWSP), a branch of the MOE. The DWSP is a voluntary program operated by the 
MOE in cooperation with municipalities to gather scientific data on drinking water quality in 
Ontario. (DWSP, 2005).  
 
The alkalinity of the Grand River also has highly variable values throughout any given year. The 
alkalinity has an average of approximately 195 mg/L (as CaCO3). The seasonal variations see the 
alkalinity drop to under 150 mg/L, and well over 240 mg/L, with highest values measured during 
the months of January and February, and the lowest values in July and August (DWSP, 2005). 
 
Turbidity was a closely monitored parameter in this research, as it plays a key role in the 
coagulation process of the raw water. The turbidity of the Grand River is influenced generally by 
human activities such as farming and the construction of dams. It also is a strong of function of 
weather impacts, such as spring run off and heavy rainfall. In 2005, the average turbidity was 
found to be approximately 4.4 NTU, with peak values of well over 100 NTU (DWSP, 2005).  
 
The temperature in the Grand River fluctuates over a wide range. In January, the average river 
temperature entering the treatment plant was recorded as being 0.63 oC, while in July of the same 
year the temperature rose to an average of 21.83 oC (DWSP, 2005).  
 
The TOC concentration found in the Grand River water varied somewhat over the year, ranging 
from 5.0 – 7.4 mg/L. TOC and DOC analysis (TOC analysis method – Section 3.6.1) was 






treatment plant low lift pumping station showed comparable results, with the TOC ranging from 
5.0-6.5, with approximately 90 % of the total concentration in the form of DOC.  
 
3.2.2 Lake Ontario (Hamilton Harbor) 
The City of Hamilton treats raw water from Lake Ontario and in its Woodward plant supplies 
Hamilton, Stoney Creek, Dundas, Ancaster, Waterdown, parts of Flamborough and Glanbrook 
with treated water. The water treatment process consists of pre-chlorination, screening, 
clarification by means of coagulation, flocculation by mechanical mixing, followed by 
sedimentation. The filtration process was upgraded in the year 1998 by the addition of granulated 
activated carbon (GAC) in the filters to remove taste and odour. This condition is usually present 
in the water in the late summer, when algae are abundant. Chlorine and ammonia are added to 
the filtered water to bring the combined chlorine residual to approximately 1.3 mg/L. Hydro-
fluosilicic acid (fluoride) is added to the drinking water to promote dental health. The Hamilton 
Woodward water treatment plant has a rated capacity of 909,000 m3/day (MOE,2005). 
 
The pH at the Woodward WTP intake was measured and the recorded at the plant intake, and 
found to be quite similar to that of the Grand River. In 2005, the pH at the intake ranged from 7.8 
– 8.2 (DWSP, 2005). 
 
The total alkalinity as CaCO3 was also measured at the plant intake and found to vary between 
80 and 100 mg/L (DWSP, 2005). 
 
Turbidity values at this WTP intake stay reasonably constant throughout the year. In 2005, the 
minimum value was around 0.3 NTU, with a maximum value recorded at 3.0 NTU. Over the 
duration of the year, the turbidity had an average value of approximately 0.6 NTU (DWSP, 
2005). 
 
The water temperature range is similar to that of the Grand River. In January, the average 
Hamilton intake water temperature was <1.0 oC, while in July of the same year the temperature 
rose to an average of 21.5 oC. The average annual temperature value was 5.0 oC (DWSP, 2005). 
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The TOC concentration in 2005 was low relative to the Grand River, ranging from 1.4 to 3.0 
mg/L (DWSP, 2005). 
 
The raw pre-chlorinated Lake Ontario water used in this research was obtained from the intake at 
the Hamilton Woodward WTP. Water was transported from the WTP to the laboratory at the 
University of Waterloo with the assistance of Environment Canada personnel in two 400L 
containers. At Waterloo, it was transferred into 25L Nalgene containers, and kept at room 
temperature for the duration of the membrane trial. The raw water was used within 72 h of 
collection. The residual chlorine concentration was measured to be approximately 1 mg/L. In 
order to ensure that no residual chlorine remained in the raw water before beginning 
experiments, the water was spiked with a 0.2 M sodium thiosulfate (NaS2O3) solution to quench 
the residual chlorine. It was assumed that thiosulfate (NaS2O3) and free chlorine (Cl2) reacted in 
a 2:1 (S2O3
2-:Cl2) ratio. Taking this into account, and adding a safety factor of 2 to the mass 
balance calculations, 7.05 mL of 0.2 M thiosulfate solution was added to every 25 L of raw water 
to ensure that no residual chlorine remained. The residual chlorine concentrations of all samples 
were verified to be below 0.02 mg/L before continuing any further experiments.  
 
Table 3-1 shows a summary of the parameters of interest. This data determined the range of 
values that were studied to try and best simulate each water type for the coagulation trials with 
the synthetic water (results described in Chapter 4). 
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3.2.3 Synthetic water cocktail 
Synthetic water was produced in bench scale quantities using ultra pure water (Milli Q, Millipore 
Inc., Billerica, MA). Kaolin (VWR International, Mississauga, ON) was used to add turbidity, 
where each mg of kaolin added to a litre of water yielded approximately 1 NTU. Turbidity levels 
ranging from 5-25 NTU were used during the synthetic water jar test trials. Alkalinity was added 
in the form of sodium bicarbonate (NaHCO3) powder (VWR International, Mississauga, ON). 
Sodium bicarbonate provided a good representation of natural alkalinity, which is typically 
expressed in terms of mg/L of calcium carbonate (CaCO3) found in solution. 1.68 mg of 
NaHCO3 provides an alkalinity equivalent to 1 mg of CaCO3. Alkalinity concentrations ranging 
from 30 – 180 mg/L were used for the trials. Natural organic matter was simulated with Aldrich 
humic acid (Sigma-Aldrich Inc., St. Louis, MO). For every 1 mg/L of TOC, 2.70 mg/L of the 
Aldrich humic acid is required. This ratio was determined experimentally by creating 5 standards 
each with an accurately measured quantity of the Aldrich humic acid solid, ranging from 1 – 10 
mg/L, and measuring TOC concentration. No amount of calcium was added to simulate the water 
hardness. 
 
The synthetic water cocktail was prepared by adding all the necessary compounds into a 1L 
beaker with approximately 900 mL of ultra-pure water, and mixing for at least 1h, ensuring that 
the humic acid dissolved. The contents of the 1L beaker were then made up to 20 L with ultra 
pure water in a plastic container which was manually shaken for 5-10 min before beginning 




Figure 3-1: Synthetic water cocktail preparation procedure 
 
3.3 Coagulation Method 
As described in detail in the literature review section, this thesis involved the use of five 
coagulants: Ferric chloride, Aluminum sulphate (Alum), and three polyaluminum chloride 
(PACl) coagulants: SternPac®, SternPac® 70 and SternPac® 2300. Ferric chloride and alum are 
two widely used coagulants both in the drinking and waste water industries. The three PACl 
products are not as well known, although the application of PACl has become more popular in 
the drinking water treatment industry (AWWA, 2005) 
 
Table 3-2 provides a summary of the coagulants used in this study. All coagulants were provided 
by the Brantford, ON, office of Eaglebrook, Inc. (Matteson, IL). 
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Table 3-2: Property of coagulants 
Coagulant
Concentration  as 
supplied (%)
% Active metal as 
supplied
Basicity %
Aluminium sulphate 0.48 4.3 N/A
PACl (SP 70) 0.4 5.5 70
PACl (SP 2300) 0.4 5.4 63
PACl (SP) 0.4 5.4 50
Ferric chloride 0.35 11 N/A  
PACL = Polyaluminum chloride 
 
The initial step in any coagulation investigation is to conduct jar testing to determine the 
optimum coagulant dose for a specified water type. As mentioned previously, a synthetic water 
cocktail was used initially to gain a more fundamental understanding of the behaviour of the 
coagulants. Numerous combinations of alkalinity, turbidity and TOC were studied to simulate 
the two Ontario source waters. 
 
Synthetic water jar test trials were conducted with all five coagulants. In order to cover the range 
of real water conditions shown in Table 3-1 above, a 2-level experimental design was performed, 
with the turbidity and alkalinity being the varied parameters. The purpose of the 2-level factorial 
design was to gain an understanding of the impact of the two water quality parameters on the 
performance of the coagulation process in removing the optimal amount of TOC. Three different 
TOC values were trialed, the lowest one representing the Great Lakes concentrations in Ontario, 
the highest concentration representing the Grand River and the mid level concentration 









# 1 20 175 2, 5 and 7
# 2 5 175 2, 5 and 7
# 3 5 30 2, 5 and 7
# 4 20 30 2, 5 and 7
 
 
The 2-level factorial design was implemented for all four coagulants, resulting in a total of 48 jar 
test trials conducted with synthetic water. Figure 3-2 shows a jar testing unit (VWR 
International, Mississauga, ON); similar to the one used for all of the jar test trials. Each jar was 
dosed with a different quantity of coagulant, and TOC, pH, alkalinity, turbidity and temperature 




Figure 3-2: Phipps and Bird Jar Testing Unit: 
 
The rapid mixing phase of all of the jar test trials was performed for 2 min at 100 rpm, 
representing a velocity gradient of 70 s-1. The slow mixing phase of all the trials was performed 
for 20 min @ 20 rpm, representing a velocity gradient of 10 s-1 (Randtke,1988). The settling 
period lasted 40 min. These time intervals were chosen as a standard jar testing practice, used for 
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both water and waste water related experiments (AWWA, 2005). Once the settling period was 
over, samples were collected by opening a pinch valve located 2“ (0.051m) above the bottom of 
the container. Samples were analyzed for TOC and DOC. Residual turbidity and pH values were 
recorded. The coagulant dose that yielded the lowest TOC concentration in the settled water was 
deemed the optimal dose, and therefore suitable for subsequent membrane treatment. 
 
3.4 Membrane and Coagulation Bench-Scale Apparatus  
The first step of this phase of the research project was to determine the configuration of the 
bench-scale membrane treatment system. Figure 3-3 shows a process flow diagram (PFD) of the 
entire membrane pre-treatment system. 
 
 
Figure 3-3: Bench scale membrane system process flow diagram 
 
The raw water tank had a capacity of approximately 75 L. The water was set in motion via a 
positive displacement peristaltic pump (Cole Parmer Inc., Vernon Hills, IL), where it was joined 
by an injected coagulant stream. The coagulant was injected via a low flow miniature gear pump 
(Cole Parmer Inc., Vernon Hills, IL).  
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The coagulant tank had 1 L capacity, and contained a diluted coagulant in a 1:10 ratio. The 
dilution was necessary to accommodate the fact that the miniature gear pump that fed the 
coagulant could not pump at flow rates low enough to meet the requirements of an un-diluted 
coagulant.  
 
The two streams combined and were fed into a 6” (0.152m) long static mixer (Koflo Corp., Cary, 
IL). The concept behind a static mixer is simple: the two fluids (water and coagulant) flowing 
through a pipe are channelled through a geometric arrangement of approximately 40 elements. 
The element geometry within the housing caused the flow to divide, mix, divide again and mix 
again, until the maximum attainable mixing was complete. The flow then continued on into a 
glass flocculation tank which had a capacity of 1.5 L.  
 
All trials were conducted with a flocculation tank influent flow of 90 mL/min, therefore yielding 
a hydraulic retention time (HRT) of 16.1 min. The mixed fluid was fed into the bottom of the 
flocculation tank, and exited via an overflow port at the top of the tank. The flocculation tank 
was cleaned every 24 h during trials, as a substantial amount of flocs would accumulate at the 
bottom of the tank. The coagulated water was fed by gravity into the acrylic membrane tank 
designed specifically for this application. The membrane tank was a cylinder, with an inner 
diameter of 3” (0.076m), and a length of 14” (0.356m). At each end, the vessel was threaded, so 
that industrial strength PVC caps were screwed in creating a water proof seal. The membrane 
unit fit snugly in the acrylic tank, with no room to move laterally. As seen in the PFD, there were 
three points of automation that allowed the system to run in a continuous batch mode: the air 
valve, drainage valve and the permeate pump. The membrane system was designed to run 
continuously without supervision, automated by a simple programmable logic controller 
(Rockwell Automation Inc., Milwaukee, WI). All trials were conducted with the following 
sequence of events: 
 
1. Permeation at 45 mL/min for 35 min 
2. Permeation stopped, backwash at 45 mL/min with air pulse at 1 ft3/min for 20s 
3. Tank drainage with air pulse at 1 ft3/min for 20 sec 
4. Membrane tank re-fill (10 min), air and permeate off 
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5. Repeat steps 1 – 4 
 
The membrane tank had a volume of approximately 1.5 L, with an overflow port installed just 
above the point where the membrane module is positioned, so as to maintain a constant head. 
With an incoming flow of 90 mL/min, and a permeate flow of 45 mL/min; 45 mL of water was 
discarded to waste every minute. This large difference between the feed and permeate flow was 
attributed to fact that the fill time of the membrane tank after drainage was aimed at being 
minimized. If the feed flow was similar to the permeate, it would take approximately 20 min to 
fill the membrane tank, and subsequently the ratio of permeate to fill time would only be 1.5:1. 
With the increased feed flow, the fill time was reduced to 10 min, increasing the ratio to 3:1. 
This ratio was deemed reasonable and held constant for the duration of all membrane trials. 










Figure 4-4: Bench scale membrane system 
 
The raw water and coagulant tanks were continuously stirred, ensuring a uniform mixture for 
both throughout the duration of all membrane trials. The raw water tank was stirred by means of 
a mechanical mixer, with a 6” (0.152 m) blade, while the coagulant tank was stirred using a 1” 
(0.025 m) magnetic stir bar. Figure 3-5 shows a close up of the membrane tank with all of its 
components. 
Raw water tank 










Figure 3-5: Bench scale membrane vessel 
 
As mentioned early, there were three points of automation built into this set up. The air intake (1) 
was connected to the top of the membrane module, and was activated with the PLC. When 
running, air bubbles were pushed through the core of the module, and exited between the hollow 
fibres. The air sparging was conducted in order to remove any loose deposits from the membrane 
surface, which subsequently were removed from the membrane tank during the drainage cycle. 
The air sparging was controlled by a standard 120V (normally closed) ¼” orifice solenoid valve 
(ASCO Valve Inc., Florham Park, NJ). The PLC would send a signal to the valve, and it would 
open for 20 s, allowing the air to travel through the membrane module. The second point of 
automation was the membrane permeation (2). When the permeate pump was running, water was 
sucked in through the pores in each of the fibres, then accumulated at the top of the module and 
exited via the T-shaped fitting and out of the tank. The third point of automation was the 
drainage of the membrane tank (3). This was accomplished with the use of a standard 120V 
Air inlet (1) 
Permeate (2) 
Drainage valve (3)  
Pressure Transducer 
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(normally closed) ½” orifice solenoid valve (ASCO Valve Inc., Florham Park, NJ). This valve 
opened when signalled by the PLC, and would return to its normally closed position after 20 s. 
During the 20 s drainage cycle, the direction of the permeate pump was reversed, and treated 
water was pumped in the opposite direction, through the hollow fibres and back into the 
membrane tank. The whole purpose of this sequence of events was to minimize the amount of 
particulate (both suspended and dissolved) that remained on the surface and in the pores of the 
hollow fibre membrane strands. 
3.4.1 Membrane Modules 
A total of 6 membrane units were used for this project. One membrane was designated for each 
of the four coagulants, and one for each of the two raw water sources. This approach was taken 
to ensure that there were no cross contaminating effects between the coagulants, and that when 
raw water was being treated, no residual coagulant was present to effect the results.  
 
Each new membrane as received from the manufacturer was vacuum sealed in a plastic wrapping 
that contained a thin coating of glycerin on the interior, so as to ensure the membrane fibres 
remained moist during transportation and storage. Prior to use, membranes were cleaning by 
running ultra pure water through them for at least 1 hour, to ensure all residual glycerin was 
removed. All 6 membranes were operated and cleaned in the same manner. After being used, the 
membranes were cleaned by submerging them in a 200 mg/L sodium hypochlorite (NaOCl) 
solution for 5-7 h, then rinsed with ultra-pure water. Membranes were cleaned after each trial, 
and stored in ultra-pure water in the refrigerator for future use. The TMP of each membrane was 
checked before beginning a 3-day trial. A clean membrane had a TMP of approximately 2.5-3 
psi. If the TMP pressure was too high, the cleaning process was repeated until the pressure 
reached an acceptable level Table 3-4 outlines the details of the membrane properties used for all 




Table 3-4: Membrane Properties 
Properties Range
Flux 30 - 70 L/m
2
h
Flowrate 1.4 - 3.3 L/h
Material PVDF
Membrane surface area 0.047 m
2
Pressure 0 - 70 kPa
Nomimal Pore Size ~ 0.035 µm
MWCO 400,000 Da
Temperature Tolerance 0 - 40 
o
C
Chlorine Tolerance 1000 ppm
pH Tolerance 2-11  
 
Throughout this project, the membrane flux held constant at 55 L/m2h, resulting in an average 
flow rate of 2.7 L/h. The pressure range over which the membrane unit functioned was a function 
of the type water being treated. For this application, the manufacturer recommended a pressure 
limit of approximately 18 psi. The nominal pore size, MWCO value and tolerances of the 
membrane units were also provided by the manufacturer. 
 
3.5 Membrane Trials Experimental Design 
The experimental program ran for approximately 6 months. All membrane trials lasted for three 
days. The membrane trials were separated into six distinct phases, which involved treatment of: 
 
1. Grand River water with optimal coagulant dose for TOC removal 
2. Grand River water with equal molar dosing 
3. Lake Ontario water with optimal coagulant dose for TOC removal 
4. Grand River water with modified mixing rates in flocculation tank 
5. Grand River water with modified raw water pH levels 




The first round of experiments involved dosing raw water taken from the Grand River with the 
coagulant dose that resulted in maximum TOC removal in the jar test trials conducted with 
Grand River water during the first phase of the project. Raw water was tested with no coagulant 
at the outset, so as to establish a reference point to which to compare all trans-membrane 
pressure (TMP) trends. Raw water was then spiked with all four coagulants separately. Each trial 
was executed the same way, with the exception of the coagulant type. The coagulant doses were 
1.8x10-4 mol Al/L (30 mg alum/L), 2.8x10-4 mol Fe/L (45 mg ferric chloride/L), 3.7x10-4 mol 
Al/L (40 mg SP/L), and 4.9x10-4 mol Al/L (50 mg SP 70/L) for alum, ferric chloride, PACl (SP) 
and PACl (SP 70), respectively.  
 
The second round of experiments involved an ‘equal molar dosing’ approach. This entailed 
choosing a dose of metal that was used four coagulants, therefore providing results that could be 
compared on that basis. The equal molar dose of 7.5 x 10-5 mol metal/L was chosen as a 
reasonable dose. It allowed for all four coagulant doses to be within 15 mg/L of the optimal dose. 
The corresponding doses were 47.1 mg/L, 38.0 mg/L, 37.5 mg/L, and 36.8 mg/ L for alum, ferric 
chloride, PACl (SP) and PACl (SP 70), respectively.  
 
The third round of experiments involved dosing raw Lake Ontario water taken from the 
Hamilton WTP with the coagulant dose that resulted in maximum TOC removal obtained with 
the jar test trials conducted before the membrane trials. This was done to ensure the required 
doses were similar to those obtained when the jar test trials were performed during the first phase 
of the project. The coagulant doses were 4.4x10-5 mol Al/L (15 mg alum/L), 1.2x10-4 mol Fe/L 
(20 mg ferric chloride/L), 8.7x10-5 mol Al/L (15 mg SP/L), and 1.2x10-4 mol Al/L (20 mg SP 
70/L) for alum, ferric chloride, PACl (SP) and PACl (SP 70), respectively.  
 
The fourth round of experiments involved the modification of the mixing rate of the mechanical 
mixer in the flocculation tank. All of the previous experiments were run at 30 rpm. For this set of 
experiments the mixing rate was raised to 45 rpm. The reasoning behind this parameter 
modification was two-fold. The first was to quantify the change in TMP as a result of an 
increased mixing rate. Under these conditions, a larger portion of the flocs were transferred from 
the flocculation tank to the membrane tank, and subsequently, more flocs had the potential to end 
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up on the membrane surface. Thus this change simulated to some extent direct filtration, whereas 
the previous trials essentially simulated the inclusion of a sediment step.  The second reason for 
this parameter modification was to determine whether the increased mixing rate would induce a 
greater TOC removal during the coagulation step. These modified mixing rates were applied to 
raw Grand River water, applying the optimal coagulant doses that were used in the first round of 
the experiments. 
 
The fifth round of the experiments involved the modification of the raw water pH to the optimal 
level for coagulation for TOC removal using the respective metal based coagulants. Optimization 
of the coagulation process for TOC removal occurs under acidic conditions: at a pH 4.5-5.5 for 
iron based coagulants and pH 5-6 for aluminum based coagulants (Sharp et al., 2006). Increased 
TOC removals should reduce the degree of membrane fouling even further than in the first stage 
of the experiments. The raw water was spiked with reagent grade hydrochloric acid (VWR 
International, Mississauga, ON) to reduce the pH. These raw water pH modification experiments 
were performed on Grand River water, applying the optimal coagulant doses that were used in 
the first round of the real water experiments. During the first round of experiments, the pH of 
coagulation always remained above 7.  
 
The sixth round of experiments involved two sets of trials, using half the optimal dose of 
coagulant obtained during the jar test trials conducted during the first phase of the research (i.e. 
half the dose used in Round 1).  Alum and SP were chosen, with doses of 15 mg/L and 20 mg/L 
for alum and SP respectively. These doses were tested to observe the difference in TOC removal 
and membrane fouling when the coagulants were severely under-dosed, and were performed 
because of indications that such lower doses were used at least sometimes in practice. 
 




Table 3-5: Membrane trials experimental design summary 
Tap water (Reference pt) None None N/A Trial period
Raw Grand River Water None None None
Raw Grand River Water Alum 30.0 1.8x10
-4 
Raw Grand River Water Ferric chloride 45.0 2.8x10
-4 
Raw Grand River Water PACl (SP) 40.0 3.7x10
-4
Raw Grand River Water PACl (SP 70) 50.0 4.9x10
-4
Raw Grand River Water Ferric chloride 38.0 7.5 x 10
-5
Raw Grand River Water Alum 47.1 7.5 x 10
-5
Raw Grand River Water PACl (SP) 37.5 7.5 x 10
-5
Raw Grand River Water PACl (SP 70) 36.8 7.5 x 10
-5
Raw Lake Ontario Water None None None
Raw Lake Ontario Water Alum 15.0 4.4x 10
-5
Raw Lake Ontario Water Ferric chloride 20.0 1.2x 10
-4
Raw Lake Ontario Water PACl (SP) 15.0 8.7x 10
-5
Raw Lake Ontario Water PACl (SP 70) 20.0 1.2x 10
-4
Raw Grand River Water Alum 30.0 1.8x10
-4 
Raw Grand River Water Ferric chloride 45.0 2.8x10
-4 
Raw Grand River Water PACl (SP) 40.0 3.7x10
-4
Raw Grand River Water PACl (SP 70) 50.0 4.9x10
-4
Raw Grand River Water Alum 30.0 1.8x10
-4 
Raw Grand River Water Ferric chloride 45.0 2.8x10
-4 
Raw Grand River Water PACl (SP) 40.0 3.7x10
-4
Raw Grand River Water PACl (SP 70) 50.0 4.9x10
-4
Raw Grand River Water Alum 15.0 9.0x 10
-5
Raw Grand River Water PACL (SP) 20.0 2.8x10
-4





Modified raw water pH with 
optimum coagulant dose
Modified HRT in flocculation 




These doses represented the 
dose for optimum TOC 
removal for coagulation for 
this water type
These doses represented the 
dose for optimum TOC 
removal for coagulation for 
this water type
Equal metal concentration 




3.6 Chemical Parameters Analysis Method 
3.6.1 Total Organic Carbon (TOC) 
Total organic carbon (TOC) was measured by wet chemical oxidation using an O/I Analytical 
1010 Wet Oxidation TOC Analyser (Graden Instruments, Oakville, ON). The method that was 
followed is described in Standard Methods: 5310 C Total Organic Carbon Persulfate-Ultraviolet 
or Heated-Persulfate Oxidation Method (APHA, AWWA, WEF, 2005). All samples were 
analyzed for TOC and dissolved organic carbon (DOC). DOC samples were obtained by filtering 
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the water through a 0.45µm poly-carbonate membrane filter. The filter was first rinsed with 200 
ml of DI and ultra-pure water to ensure no residual organics remained on the surface of the 
membrane. Following filtration, all samples were acidified to a pH of approximately 2.0 for 
preservation. Samples were stored in the refrigerator for up to three weeks before analysis. 
3.6.2 Alkalinity 
Alkalinity was quantified according to Standard Method 2320B (APHA, AWWA, WEF, 2005). 
All samples were analyzed in duplicate. 
3.6.3 pH 
pH was measured using the ORION model 420A pH meter (Pollard Water, New Hyde Park, 
NY). All samples were analyzed in duplicate. 
3.6.4 Chlorine 
The residual chlorine in the raw water was quantified using the Hach Kit method of measuring 
chlorine (Hach Co., Loveland, CO), which is based on the Colorimetric Method according to 
Standard Method 4500-Cl DPD (APHA, AWWA, WEF, 2005). All samples were analyzed in 
duplicate. 
3.6.5 Conductivity 
Conductivity in the raw, flocculated, and treated waters was measured using a portable handheld 





3.7 Physical Parameters Analysis Method 
3.7.1 Turbidity 
Turbidity was measured with a portable hand held Hach 2100P turbidimeter (Hach Co., 
Loveland, CO). Turbidities of the raw, flocculated and treated waters were measured and 
recorded. All samples were analyzed in duplicate. 
 
3.7.2 Trans-membrane Pressure (TMP) 
TMP was recorded with a gauge pressure transducer Model 68075 (Cole Parmer Inc., Vernon 
Hills, IL) at the point where the treated water exited the membrane unit. This instrument read the 
current, and outputted a value between 4 and 20 mA. This current was proportional to the TMP 
according to the following relationship: 
 
Pressure (psi) = -1.875*Current(mA) + 22.5  (4) 
 
A current reading was taken by the pressure transducer every 20 sec, and stored in a data logger. 
At the end of all experiments, the data was uploaded onto a computer in the form of a 
spreadsheet. The TMP value was defined as the following: 
 
TMP (psi) = Pout – Pin = ∆P  (5) 
 
The pressure transducer read the effluent pressure as a negative value, as the positive 
displacement peristaltic pump is providing a vacuum, therefore, the harder the pumps needs to 
pull to maintain a flow of 45 mL/min, the lower the current that was emitted. 
3.7.3 Total Suspended Solids (TSS) 
TSS was measured for raw, treated and flocculated waters for the last two of three rounds of the 
experimental design. TSS is reported in terms of mg of suspended solids/L of solution; it is 
quantified using a filtration method described as the total suspended solids dried at 103-105oC 
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method according to Standard Method 2540D (APHA, AWWA, WEF, 2005). All samples were 
analyzed in duplicate. 
3.7.4 Fractionation Method 
The raw and treated waters were fractionated in order to gain a better understanding of what 
fractions of the NOM contribute to fouling most. The fractionation of any water sample can be 
based on a number of characteristics, but the most useful method for this research project was to 
fractionate the NOM in the raw and treated waters in terms of molecular weight.  
 
This method involved the use of a series of UF filtration filters (Millipore Inc., Billerica, MA) 
with different molecular weight cut offs (MWCO) to sequentially separate the water into a series 
of molecular weight fractions. The first step of the method was filtering the water through a pre-
rinsed 0.45 µm hydrophilic polypropylene filter ((VWR International, Mississauga, ON)) in 
order to remove any suspended solids that existed in solution. Before starting a filtration, the UF 
filters were first soaked 3 x 10 minutes in ultra pure water, and then 250 mL of de-ionized water 
was filtered, ending with 250 mL of ultra pure water before filtering the sample. This thorough 
cleaning method was conducted to ensure that any residual organics that were on the surface of 
the UF discs were removed, before beginning the fractionation experiments. 
 
There were a total of five filter UF types used during the fractionation experiments, each having 
a different MWCO: 30 kDa, 10 kDa, 3 kDa, 1 kDa and 500 Da. The filters were made of 
regenerated cellulose (30 kDa - 1 kDa) and cellulose acetate (500 Da), all having a 76 mm 
diameter. The filters were inserted into a pressurized stirred cell apparatus (Millipore Inc., 
Billerica, MA) and immobilized within a plastic casing. The top of the fractionation cell was 
connected to a nitrogen tank, which provided pressure to the cell and in doing so, create a 




Figure 3-6: Bench-scale fractionation apparatus 
 
Nitrogen gas was provided at variable pressures, as each filter required a different pressure to 
maintain a consistent flow without damaging the membrane. The method called for a permeate 
flow to be between 1 mL/min and 10 mL/min. The optimum lay at about 8 mL/min, with a 
maximum allowed pressure of 60 psig, based on guidelines described by the membrane supplier. 
The general pressure ranges were as follows: 
 
• 30 kDa = 20 psi (1.38 bar) 
• 10 kDa = 20 - 30 psi (1.38 - 2.07 bar) 
• 3 kDa = 30 - 50 psi (2.07 - 3.45 bar) 
• 1 kDa = 50 - 55 psi (3.45 - 3.79 bar) 
• 500 Da = 60 psi (4.14 bar) 
 
A 50 mL sample was taken from each fractionation, as well as a blank to ensure residual 
organics did not remain on the membrane surface. TOC samples were acidified with phosphoric 
acid in the same way as all other samples, and stored in the refrigerator until analysis was 
performed. After each usage, the filters were soaked in a 0.1 M NaOH + 100 mg/L bleach 
solution for 30 minutes, then rinsed 3 x 10 minutes in ultra pure water before being put in their 
respective storage solutions. 
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Each filter was used a maximum of three times, and stored in a 10 % ethanol solution between 
uses for the regenerated cellulose filters and 0.05 % sodium azide solution for the cellulose 
acetate filter. 
 
3.8 Standards and Quality Control 
One of the most important aspects of any analytical analysis is to ensure consistent results are 
obtained. This research focused on specific methods that aimed at quantifying a particular 
substance in water, and comparing these results to those obtained earlier using the same method. 
Therefore, in order to ensure that the data obtained were statistically sound, a certain set of 
procedures was followed when sampling and/or analyzing water samples:  
• Water quality parameters were always tested in duplicate, or in some cases in 
triplicate 
• During the TOC analysis runs, a calibration curve was utilized, making use of 
standards and blanks to verify the instruments accuracy 
• Sample containers were always thoroughly cleaned and rinsed with sample before 
















CHAPTER 4  
 
PRELIMINARY COAGULATION AND WATER QUALITY 
RESULTS 
4.1 Introduction and Objectives 
The following section describes the results obtained from the series of jar test trials performed in 
the early stages of the research project. As previously mentioned, a 2-level factorial design was 
implemented with the synthetic water cocktail, in order to obtain a better understanding of how 
alkalinity, turbidity and the level of TOC affect the coagulation process for the waters tested. 
Results from the jar test trials conducted with raw Grand River and Lake Ontario water will be 
provided in this section. The objectives for this phase of the research were as follows: 
• To gain a better understanding of how the four coagulants behaved when exposed 
to variations in turbidity, alkalinity and TOC 
• To establish an optimum coagulant dose that yields maximum TOC removal for 
each of the four coagulants, to be used as a reference point for all subsequent 
membrane trials 
• To describe the effect of the coagulant on the two raw water sources 
 
4.2 Jar Test Trials with Synthetic Water Cocktail 
All of the synthetic jar test trials were conducted in the same manner. Results were tabulated and 
a plot of dose vs. TOC and turbidity was generated for each individual jar test. Figure 4-1 is an 
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Residual Turbidity (Alk-30mg/L) Residual TOC (Alk-30mg/L)  
Figure 4-1: Alum dose vs. residual TOC and turbidity (synthetic water) – 30 mg CaCO3/L, 
20 NTU, 5 mg/L TOC 
 
This synthetic water cocktail was created with an alkalinity of 30 mg CaCO3/L, a turbidity of 
approximately 20 NTU and TOC concentration of 5.1 mg/L, as outlined in the jar test trials 
design in Table 3-3. The optimal coagulant dose was identified as the dose that corresponded to 
the lowest residual TOC value.  In the case shown in Figure 4-1, the optimal dose was 1.3x104 
moles of Al/L, which corresponded to a coagulant dose of 35 mg/L of alum. The TOC was 
reduced to 0.6 mg/L, yielding an 88 % removal, while the turbidity was reduced from 20 NTU, 
down to 2.1 NTU, yielding a 90 % removal. Table 4-1 provides a summary of the results , based 
on Figures A.1 to A.9 and A.22 to A.27 found in Appendix A, obtained from the synthetic jar 
test trials conducted with alum and ferric chloride. As clearly seen, both coagulants performed 
very well when exposed to the synthetic water cocktails, with ferric chloride having a slightly 
better ability to remove TOC at an optimal dose. Their effect on pH was also noted, with the 




Table 4-1: Summary of Alum and ferric chloride jar test coagulation results 
Condition Alum Ferric chloride
Fast floc formation (3-5 min) Slower floc formation 
Settled moderately fast (20 min) Settled quickly (15 min)
60-75% removal with high 
alkalinity (>100 mg/L)
65-75% removal with high 
alkalinity (>100 mg/L)
40-45% removal with low 
alkalinity (<50 mg/L)
50-60% removal with low 
alkalinity (<50 mg/L)
Higher percentage removal at 
higher TOC   concentrations
Higher percentage removal at 
higher TOC concentrations
pH Moderate effect on pH (pH drop 
~0.8 units at dose of 50 mg/L)
Large effect on pH (pH drop 
~1.0 units at dose of 50 mg/L)
Turbidity   removal Good turbidity removal (1 NTU 
residual)






Table 4-2 provides the summarized data for the jar test trials conducted with the two pre-
hydrolyzed coagulants, PACl (SP 70) and PACl (SP).  
 
Table 4-2: Summary of PACl (SP 70) and PACl (SP) jar test coagulation results 
Condition PACl (SP 70) PACl (SP)
Large/fast floc formation Moderate size floc formation
Settled very quickly (10 min) Settled quickly (15 min)
65-75% removal at high alkalinity 75-85% removal at high 
alkalinity
40-50% removal with low 
alkalinity (<50 mg/L)
50-60% removal with low 
alkalinity (<50 mg/L)
Higher removal at higher TOC     
concentrations
Higher removal at higher TOC  
concentrations
Highest removal with a dose of 40-
50 mg/L
Highest removal with a dose of 
35-40 mg/L
pH Small effect on pH (pH drop ~0.4 
units at dose of 50 mg/L)
Moderate effect on pH (pH drop 
~0.7 units at dose of 40 mg/L)
Turbidity  removal Good turbidity removal (<1 NTU 
residual)







These coagulants are not as widely used as the two conventional coagulants described above, and 
their use in drinking water applications is not nearly as widespread. The results obtained were 
very promising, with both coagulants yielding high TOC removal rates, comparable to the 
conventional coagulants. One important point to note is that the changes in pH for the two pre-
hydrolyzed coagulants were substantially lower, only reducing the pH by 0.4 and 0.7 units at the 
optimal coagulant dose for SP 70 and SP respectively. This contrast between the two sets of 
coagulants provides valuable information to assist manufacturers and plant operators with 
respect to the implementation of techniques to optimize membrane treatment processes for 
reducing membrane fouling. The fact that the pre-hydrolyzed coagulants do not lower the pH 
level a great deal implies that less resources and energy may have to be invested in order to bring 
the water back to a pH level that is acceptable for release into the distribution system.  
 
The high alkalinity synthetic water cocktails (175 mg/L CaCO3) showed better coagulation 
performance as compared to the low alkalinity waters (30 mg/L CaCO3). This finding is 
supported by studies performed by O’Melia et al., 1999, which showed that higher alkalinity 
waters were easier to coagulate because of the higher concentration of positively charged 
calcium ions that interact with the negatively charged colloids. These results were seen across all 
four coagulations: the synthetic water trials conducted with the increased alkalinity resulted in a 
greater TOC removal, on average approximately 15-25 percentage points for all four coagulants.  
 
Coagulating low alkalinity waters can be difficult because the pH may drop too far and because 
the lower calcium level may lead to less effective co-precipitation of the dissolved organics. A 
disadvantage of the low alkalinity is that the addition of an excessive amount of coagulant to 
satisfy demand could reduce the pH below the optimal range. Having said this, a similar problem 
exists for high alkalinity waters, where the selected dose may yield a pH well above the optimum 
level for removal of organics (Randtke, 1988). These issues aid in the decision making of a 
coagulant type, when assessing the water quality and desired removal. The PACl coagulants 
would be preferred for the low alkalinity waters, since their effect on pH is substantially less as 
compared to the two conventional coagulants. The removal efficiencies are reduced at low 
alkalinity levels (Table 4-2), but this would be countered with a minimal effect on the pH. If the 
raw water had a high alkalinity, similar to that used during those jar test trials with an alkalinity 
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level of 175 mg/L CaCO3, the two conventional coagulants would be better suited for 
application. Their effect on pH was greater (Table 4-1), and therefore, brought the pH level down 
closer to the optimal range for both coagulants, which was 5 and 5.5 for ferric chloride and alum 
respectively. 
 
Raw water turbidity (5 vs. 20 NTU) was less important for determining coagulant dose, as 
compared to the raw water TOC concentration and alkalinity. This confirms results reported by 
Edzwald, (1990). There were no distinct observed trends which demonstrated that the optimal 
coagulant dose and residual TOC concentration were a function of the raw water turbidity. 
Having said this, NOM removal is generally maximized under the same conditions that provide 
optimal turbidity removal (Randtke, 1988). This trend was certainly seen throughout the majority 
of the synthetic water jar test trials, where TOC and turbidity were optimally removed with a 
similar coagulant dose (Figures A.10 to A.21, Appendix A). The residual TOC and turbidity 
trend lines generally had a similar shape. The lowest residual TOC concentration corresponded 
to the lowest turbidity value for the majority of the plots. 
 
4.3 Jar Test Trials with Grand River Water 
Triplicate measurements were performed on Grand River raw water in February, 2006 yielding 
an average of 6.31 mg/L and 6.02 mg/L for TOC and DOC, respectively. The water had a 
turbidity of approximately 8.1 NTU, alkalinity value of 181 mg/L and pH value of approximately 
7.9. These water quality parameters were measured again in August, 2006, prior to beginning the 
membrane trials. The results obtained in August were 6.81 mg/L and 6.33 mg/L for TOC and 
DOC respectively. The water turbidity was slightly lower, at 7.2 NTU, the alkalinity level was 
185 mg/L, and the pH was 8.1. 
 
The average TOC removals were approximately 53, 39, 56 and 64 % for alum, ferric chloride, 
SP and SP 70, respectively, based on the results shown in tables B.5-B.8 (Appendix B). All of 
the tabulated data associated with these plots and the results described above can be found in 
Appendix B. These values were recorded as an average of the two highest removals for each of 
the four coagulants. These optimal removals were only 5-15% higher than all of the removals 
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combined for each of the four coagulants. In all cases DOC represented between 85-95 % of the 
TOC, leaving only 5-15 % of the TOC as suspended organic carbon. The turbidity removals 
were all reasonably good, with alum and SP 70 having the highest removals, lowering the 
turbidity down to approximately 0.5 NTU. Ferric chloride and SP removals were not as high, but 
still these two coagulants lowered the turbidity to approximately 1.0 NTU. The changes in pH 
were also recorded in duplicate measures, with the two pre-hydrolyzed coagulants having the 
least effect on pH, and ferric chloride having the largest effect. At a dosage of 50 mg/L, the 
change in pH was measured as being 0.73, 0.86, 0.46 and 0.32 units for alum, ferric chloride, SP 
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Residual Turbidity Residual TOC Residual DOC  
Figure 4-5: (SP 70) dose vs. residual TOC/DOC and turbidity (Grand River) 
 
As clearly seen in Figures 4-2, 4-4 and 4-5, the TOC and DOC concentrations dropped off 
quickly initially, and then the concentrations decreased gradually until they reached a minimum 
level. The ferric chloride plot (Figure 4-3) showed a slightly different trend, where the TOC and 
DOC concentrations decreased slowly, until they leveled off at a concentration of 2.8x10-4 mol 
Fe/L, equivalent to a dose of 45 mg/L. The optimal TOC removal for the aluminum based 
coagulants was 1.8x10-4 mol Al/L (30 mg/L as alum), 4.8x10-4 mol Al/L (50 mg/L as PACl) and 
3.7x10-4 mol Al/L (40 mg/L as PACl) for alum, SP 70 and SP, respectively.  
It can also be seen in the figures that with a higher coagulant dose, re-stabilization of the 
particles occurred; causing a slight increase in the TOC concentration. Table 4-3 shows a 
summary of the optimal doses, as well the effective dose ranges determined from these trials for 
the four coagulants. 
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PACl (SP 70) 4.8x10
-4
 (50 mg/L) 50-60 mg/L
PACl (SP) 3.7x10
-4
 (40 mg/L) 40-50 mg/L
Alum 1.8x10
-4 
(30 mg/L) 20-40 mg/L
Ferric chloride 2.8x10
-4
 (45 mg/L) 30-50 mg/L
 
 
According to the pH data showin in Appendix B, all four of the coagulants were operating in the 
sweep floc range (MWH, 2005). Figure 4-4 is the only one clearly showing a TOC increase with 
an elevated dose. Figures 4-3, 4-4 and 4-5 show a clear rise in turbidity, but no rise in TOC.  
Figure 4-2 showed no similar trends, as both the turbidity and TOC leveled with an elevated 
coagulant dose. These trends implied that there existed an optimum dose of coagulant that 
corresponded to the neutralization of the negatively charged particles. With a higher than optimal 
dose, the TOC concentration rose as a result of the overall charge in the water being slightly 
positive. This caused the incomplete coagulation of the colloids, and subsequently re-
stabilization occurred. The variation in the results found between the four coagulants could be 
heavily attributed to experimental variability. More accurate results would have been obtained if 
these trials were repeated twice, and the results obtained as an average of the two trials. 
 
4.4 Jar Test Trials with Lake Ontario Water 
Triplicate measurements were performed on quenched Lake Ontario raw water in October, 2006 
yielding an average of 2.67 mg/L and 2.42 mg/L for TOC and DOC, respectively. As a reminder, 
the quenching process involved spiking the chlorinated water with a 0.2 M sodium thiosulfate 
(NaS2O3) solution to ensure no residual chlorine remained in the water prior to conducting any 
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experiments. The water had a turbidity of approximately 0.6 NTU, an alkalinity level of 104 
mg/L, and pH value of approximately 8.0. The water sampled from Lake Ontario was quite 
different from the Grand River water when comparing the solids concentration. The Grand River 
had a TOC concentration three times higher, and a turbidity level thirteen times that of Lake 
Ontario water.  Having said this, the pH was quite similar, both very close to 8.0.  The alkalinity 
of the Grand River water was greater, but nevertheless, both were above 100 mg/L. 
 
The detailed data for the jar tests can be found in Appendix B. The average TOC removal was 
approximately 48, 52, 47 and 42% for alum, ferric chloride, SP and SP 70, respectively. These 
values were recorded as an average of the two highest removals for each of the four coagulants. 
Similar to the TOC removal values obtained with the Grand River water, these optimal removals 
were only 10-15% higher than all of the removals combined for each of the four coagulants. In 
all cases DOC represented between 80-90 % of the TOC, leaving only 10-20 % of the TOC as 
suspended organic carbon. The turbidity removals were all reasonably good, with ferric chloride 
and SP having the highest removals, lowering the turbidity down to approximately 0.15 NTU. 
Removals observed with alum and SP 70 were not as high, but still these coagulants lowered the 
turbidity to approximately 0.3 NTU. The changes in pH were also recorded in duplicate 
measures, with the two pre-hydrolyzed coagulants having the least effect on pH, and ferric 
chloride having the largest effect. At a dosage of 20 mg/L, the change in pH was measured as 
being 0.36, 0.39, 0.27 and 0.20 for alum, ferric chloride, SP and SP 70 respectively. Figures 4-6 
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Residual Turbidity Residual TOC Residual DOC  
Figure 4-9: PACl (SP 70) dose vs. residual TOC/DOC and turbidity (Lake Ontario) 
 
As clearly seen in the figures, the TOC and DOC concentrations dropped off with coagulant dose 
at a much slower rate in comparison to trials conducted with Grand River water. The 
concentrations gradually decreased until they reached a minimum level. The SP plot showed a 
slightly different trend, where the TOC and DOC concentrations decreased more quickly, until 
they leveled off at a concentration of 1.4x10-4 mol Al/L, equivalent to a dose of 15 mg/L. The 
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dosage at optimal TOC removal for the other coagulants was 9.0x10-5 mol Al/L (15 mg/L as 
alum), 1.2x10-4 (20 mg/L as ferric chloride) and 1.9x10-4 mol Al/L (20 mg/L as PACl) for alum 
ferric chloride and SP 70 respectively  
 
Similar to results obtained using Grand River water, it can be seen in the figures that with a 
higher coagulant dose, re-stabilization of the particles occurred; causing a slight increase in the 
TOC concentration. Table 4-4 shows a summary of the optimal doses, as well the effective dose 
ranges for the four coagulants. 
 





PACl (SP 70) 1.9x10
-4
 (20 mg/L) 15-20 mg/L
PACl (SP) 1.4x10
-4
 (15 mg/L) 10-20 mg/L
Alum 9.0x10
-5 
(15 mg/L) 10-20 mg/L
Ferric chloride 1.2x10
-4
 (20 mg/L) 20-25 mg/L
 
 
Comparing the optimal TOC removals for the two sets of raw water shows that for all the 
coagulants except ferric chloride, trials conducted with Grand River yielded higher removals. 
The Grand River trials yielded removals that were higher by 5, 9 and 22 % for alum, SP and SP 
70, respectively. The jar test trials conducted with ferric chloride yielded removals that were 13 
% lower for the Grand River water, as compared to the Lake Ontario water. 
 
As with the Grand River water the jar test trials conducted with the Lake Ontario water showed 
trends that lead to the conclusion that sweep flocculation was the dominant particle removal 
mechanism, primarily attributed to the elevated pH that was seen throughout the trials, This was 
also due to the fact that the TOC and turbidity concentrations were higher at elevated coagulant 
doses. NOM is generally considered to be removed through colloidal destabilization and charge 
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neutralization (Randtke, 1988), so therefore the results were a bit unexpected given that sweep 
flocculation was the dominant mechanism for both the Grand River and Lake Ontario trials 
 
4.5 Summary and Conclusions 
The two raw water sources studied during the jar test trials display a variety of contrasting 
characteristics. Their TOC levels differed greatly, as did their turbidity levels. The TOC levels 
were three times that of the Lake Ontario water, while the turbidity levels were 10-15 times as 
high in the Grand River water. Because of this, the required coagulant dose to reduce the 
concentration of NOM to an optimal level also varies a great deal. Table 4-5 provides a concise 
summary of the doses that yielded the highest TOC removals for both raw water sources.   
 
Table 4-5: Jar test trials results summary 
Coagulant
TOC removal at 
high alkalinity
TOC removal at 
low alkalinity
Grand River 
optimum dose & 
TOC removal
Lake Ontario 
optimum dose & 
TOC removal
PACl (SP 70) 60-75% 35-45% 50 mg/L / 64% 20 mg/L / 42%
15 mg/L / 48%
Ferric chloride 80-95% 50-60% 45 mg/L / 39% 20 mg/L / 52%
Alum 60-70% 35-45% 30 mg/L / 53%
15 mg/L / 47%PACl (SP) 70-85% 40-50% 40 mg/L / 56%
 
 
The first two columns summarize the work conducted with the synthetic water cocktails, 
reinforcing the fact that the alkalinity level in the water affected the coagulant performance, and 
subsequently, the degree to which the NOM was removed. As previously mentioned, water with 
a higher alkalinity is preferred for coagulation since it tends to have more positively charged 
sodium bicarbonate molecules to interact with the negatively charged colloids (O’Melia et al., 
1999). The low level alkalinity water had a much lower concentration of the sodium bicarbonate 
molecules to react with the NOM particles, and therefore, a small fraction ended up in the floc 
formation. The hydrolysis reactions that occurred during the multi-stage coagulation process 
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required the presence of these molecules. When the coagulants were added to the raw water, the 
ensuing hydrolysis reactions produce hydrogen ions that reacted with the alkalinity species in 
solution (AWWA, 1999). This theory again, explained the fact that the observed TOC removals 
were much lower for all four coagulants at a lower alkalinity level.  
 
The development and manufacturing of coagulants for the water treatment industry is on ongoing 
process. The hydrolyzing metal salt (HMS) and PACl coagulants differ most in the manner in 
which they are produced. The PACl products underwent a pre-hydrolysis step during the 
manufacturing stage of the coagulant. This step involves the partial reaction of the simple salts 
(partial hydrolysis) to form the active monomeric hydrolysis species, and possibly some of the 
polynuclear species: which included Al2(OH)2
4+ and Al3(OH)
4+. The variations in the results 
shown in Table 4-5 were primarily attributed to the wide range of hydrolysis products that were 
present in the water. The active species that were created during the partial hydrolysis interacted 
with the colloids and NOM differently, subsequently yielding different removal rates. For both 
PACl coagulants, the required dose was higher than the HMS coagulants. The SP 70’s partial 
hydrolysis mechanism was carried out to a further extent as compared to the SP coagulant, and 
therefore its removal capacity was on average 5-10 % lower. The ferric chloride had the highest 
TOC removal capacity, which was expected given that a larger and heavier floc formation was 
observed for this coagulant throughout the duration of the jar test trials. 
 
The next section presents the results obtained from membrane treatment trials conducted with the 
four coagulants, and two raw water sources discussed in this chapter.  The results obtained from 
the jar test trials that were conducted served two major purposes: gain a fundamental 
understanding of how the four coagulants behaved when exposed to the two different source 






CHAPTER 5  
 
MEMBRANE TREATMENT TRIALS RESULTS 
5.1 Introduction and Objectives 
The following section describes the results obtained from the series of membrane trials 
performed during phase II of the research.  There were a total of 20 trials performed, each lasting 
a total of three days. As previously mentioned, all of the trials were performed using the bench-
scale UF membrane system described in Chapter 3 of the thesis. During each trial period, Trans-
membrane pressure (TMP) values were collected and comparative results can be seen in this 
chapter highlighting how the different coagulants performed as a pre-treatment to the UF 
membrane system. Both Grand River and Lake Ontario results are presented, so to be able to 
make a comparative assessment of the treatment process, when comparing two completely 
different raw water sources. The objectives for this phase of the research were as follows: 
 
• To quantify the effect of the four coagulants in terms of their ability to reduce 
organic fouling of the UF membrane 
• To examine the TOC/DOC removal capabilities of the four coagulants, alone and 
in combination with the UF membrane 
• To observe the impact of pH and mixing rate on TOC/DOC reduction and fouling 
control. 
 
All of the membrane trials were conducted between the months of July and December, 2006. 
Each membrane trial was carried out in the same manner. TMP data was collected, along with all 
of the water quality data, with all the information presented in this chapter. Each membrane trial 
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yielded approximately 12,900 TMP data points, and all of these raw data plots can be seen in the 
Appendix C. In order to show the three day trends, 25 TMP values were selected, to yield 
corresponding summary plots. These plots are presented in this section. 
 
5.2 Membrane Treatment Trials Using Grand River 
Figure 5-1 shows an example of one of the raw TMP plots that included the 12,000 data points. 
This plot represents the results from the Grand River membrane trial conducted with the use of a 








































Figure 5-1: Raw Grand River water - 3 day membrane trial                                                 
(45 mg/L ferric chloride pre-treatment) 
 
 
As seen in the above figure, the trans-membrane pressure was approximately 2.75 psi (6.9 kPa) 
at the beginning of the trial. Each of the points on the figure represents a pressure value that was 
logged by the pressure transducer. The connecting lines are included to show trend that the series 
of points create. Over a 3-day period, one can see how the points bunch up to create an 
increasing trend line. As previously mentioned, a clean membrane unit required a pressure 
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between 2.5-3.0 psi to produce a permeate flow of 45 mL/min. This plot and all of the remaining 
membrane treatment trials will be described in the subsequent sections of this chapter. 
5.2.1 Membrane trial using optimal coagulant doses 
Figure 5-2 shows a summary of the Grand River membrane trials conducted with the optimal 
coagulant doses of all four coagulants. Each of the five plots represents a trend line extracted 
from the raw data plots. These doses were determined during the jar test trials discussed in 


























No coagulant Alum at 30 mg/L FC at 45 mg/L SP 70 at 50 mg/L SP at 40 mg/L
Difference of 5 psi
 
Figure 5-2: Grand River membrane treatment summary                                              
(optimal coagulant doses vs. raw water) 
 
Alum performed the best at reducing the membrane fouling, with a final TMP of 5.3 psi, as 
compared to the raw water membrane trial, which yielded a final TMP of 12.5 psi, representing a 
57 % reduction in overall TMP. The three other coagulants yielded TMP reductions of 44 %, 46 
% and 40 % for ferric chloride SP and SP 70 respectively. It was surprising to see that the trials 
conducted with alum outperformed both PACl coagulants, given that better TOC removals were 
achieved during the jar test trials with SP and SP 70 at optimal does, as compared to alum. At 
first, this seemed counterintuitive, given that a larger TMP reduction would be expected with an 
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increased TOC removal. Although in this case, it seems that the reason the fouling was reduced 
for the alum trial is because this coagulant was more efficient at removing the fraction of TOC 
that causes membrane fouling. So therefore, these results show that although alum was not the 
best at reducing the overall TOC concentration, but it was in fact the most efficient at removing 
the fraction of TOC that caused fouling on the UF membrane (How and Clark, 2002b). Looking 
at the results in terms or relative coagulant dose, there exists a bit of a trend, as alum was the 
most efficient at reducing fouling, but also had the lowest coagulant dose. SP 70 in this case, 
performed the worst at reducing fouling, and had the highest coagulant dose, at 50 mg/L. These 
results support the notion that in many cases, if the coagulant remains in solution, it can 
contribute to membrane fouling.  In the case of the two pre-hydrolyzed coagulants, the increased 
dose may have resulted in the coagulant ending on the surface or inside the pores of the 
membrane.  Having said this, similar studies have been performed with regenerated cellulose 
membranes, discovering elevated concentrations of PACl products yielded a more consistent flux 
across the membrane surface, and in turn reduced the degree of fouling that occurred (Laine et 
al., 1999). 
 
The four pre-treatment trend lines showed similar shapes. All of them showed a gradual increase 
in TMP, followed by a small decrease in the slope a small amount towards the end of the trial. 
However, the raw water (no pre-treatment) trend line showed much different results. In this case, 
the TMP increased quickly until it reached a value of 12 psi halfway through the three-day trial, 
and then stabilized, with negligible increases in TMP observed over the remaining time. This 
trend can be described by the fact that the high concentration of solids in the raw water adsorbed 
to the majority of the available sites on the surface and/or inside the pores of the membrane 
during the first day, which contribute to the sharp increase in TMP over the first day. Once the 
majority of sites were occupied and the cake resistance stabilized, the rate of fouling became 
more constant, increasing only 1-2 psi over the last two days. 
 
Overall, all four coagulants showed good results as pre-treatments to the UF membrane when an 
optimal dose for TOC removal was employed. The reduction in TMP ranged from 40-57 %, 
which would definitely translate into substantial financial savings, if this process were to be 
extrapolated onto a pilot, or even a full scale system (Judd and Hillis, 2001). Interesting to note, 
 81 
a similar study was conducted, that combined coagulation treatment with membrane filtration 
using a polypropylene membrane. An alum dose of 35 mg/L reduced the quantity of reversible 
fouling by a substantial amount. Moreover, it was discovered that similar results could be 
achieved by filtering the feed water through a 0.2 µm filter, thereby removing the particulates 
that were contained in the water. This comparative work highlighted the fact that the coagulation 
in this case was successful at removing particulate foulants, but had no noticeable effect on the 
dissolved material (Carroll et al., 2000). 
 
Table 5-1 presents a concise summary of the TOC and turbidity removal data for these sets of 
membrane trials. Samples were taken from the membrane system on a daily basis in duplicate. 
The first column are results from samples taken after the coagulation and flocculation steps 
occurred, and the second column represents results obtained after membrane permeate samples 
were analyzed. The difference in TOC concentration and turbidities between the permeate stream 
and coagulation/flocculation effluent samples was equivalent to the quantity of TOC removed by 
the membrane. Therefore, the calculated removals were not cumulative, as the values shown 
below represent the individual processes, meaning that the basis for the membrane removals was 
the water being fed into the membrane, and not the raw water being fed into the system. 
 






removed by UF 
membrane
Ferric chloride 55-65% / 60-70% 5-10% / 99%
Alum 50-55% / 70-75 % 5-10% / 99%
5-10% / 99%50-55% / 70-75 %PACl (SP 70)




As seen in the above table, all four coagulants performed moderately well at removing the TOC 
in the form of NOM. When compared to the jar test trials, which represented ideal conditions for 
coagulation, the removal rates were lower, but only by 10-20 percentage points across all four 
coagulants. The turbidity removals were also consistent across the four coagulants throughout 
the coagulation stage. SP showed the highest removals at 75-80 %, and ferric chloride the lowest, 
but still a good removal at 60-70 %.  
 
It was expected to observe trends showing ferric chloride yielding the highest TOC removal, as 
ferric coagulants generally achieve greater NOM removals, as compared to aluminum-based 
coagulants (Fearing et al., 2004). The UF membrane unit did very little at reducing the level of 
TOC in the treated water. This membrane was designed to primarily target suspended solids, and 
not dissolved organic matter, which constituted most of the TOC. Having said this, although it 
was difficult to isolate the exact fouling mechanism, adsorption within membrane pores is 
dominant for UF membranes, and is less reversible than cake formation. (Carroll et al., 2000). It 
has also been concluded by several investigators that that the amount of DOC in raw water is not 
a predictor of the amount of fouling, i.e. lower raw water DOC does not correspond to less 
fouling (e.g. Best et al., 2000). Moreover, it would be very interesting to observe the fouling 
rates of the raw Grand River water during a different season, when the TOC composition and 
TOC levels are different. 
 
As previously mentioned, the nominal MWCO of the membranes was approximately 400,000 
Da, whereas the majority of the NOM in the Grand River was smaller than 10,000 Da in size. 
Therefore, it was expected to observe very little TOC removal through the membrane. The 
turbidity was very well removed by the membrane, with the permeate stream having a value 
consistently below 0.15 NTU. These results were also expected, as the UF membrane was 
designed to target turbidity in the form of particulate matter, which is much larger in size than 
the NOM. The membrane effluent turbidity showed no signs of being a function of the raw water 
turbidity, as the influent varied between 5-12 NTU. The lack of a relationship between influent 
turbidity and permeate turbidity is also expected, since the membrane provides an absolute 
barrier to particles. 
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5.2.2 Membrane trial using equal molar dosing 
Figure 5-3 shows a summary of the Grand River membrane trials conducted with the equal molar 
coagulant doses of all four coagulants. Similar to results presented with the optimal doses, the 
raw water plot is shown in blue, with the four pre-treatment plots shown underneath. These doses 
were pre-determined while creating the experimental design, when it was decided on 7.5x10-5 
mol of metal/L as the molar dose. This dose corresponded to 47 mg/L, 36 mg/L, 36 mg/L and 37 
mg/L for alum, ferric chloride, SP and SP 70 respectively. The equal molar dose was chosen as 
























No coagulant SP at 37 mg/L SP70 at 37 mg/L Alum at 47 mg/L FC at 36 mg/L
Difference of 1.5 psi
 
Figure 5-3: Grand River membrane treatment summary 
(Equal molar metal dose vs. raw water) 
 
SP performed the best at reducing the membrane fouling, with a final TMP of 8.7 psi, 
representing a 30 % reduction in overall TMP. The three other coagulants yielded TMP 
reductions of 14 %, 24 % and 18 % for alum ferric chloride and SP 70 respectively. As will be 
discussed on the next page, the results obtained from this set of membrane trials reinforced the 
fact that for this specific water the optimal dose for coagulation worked well as a dose for a 
membrane pre-treatment application. The experimental apparatus was designed to simulated a 
settled water treatment system, therefore it was desired to remove as many as the flocs as 
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possible. The equal molar doses generated flocculated water that contained more suspended 
solids, and therefore more fouling occurred. 
 
Figure 5-4 and Figure 5-5 highlight the differences between the trials conducted with the optimal 

























No coagulant SP (EM) SP (optimal) SP 70 (EM) SP 70 (optimal)
 
Figure 5-4: Grand River membrane treatment summary                                                 
(PACl products - equal molar vs. optimal dose) 
 
The equal molar doses for both of these coagulants (36 and 37 mg/L) were below their respective 
optimal doses (40 and 50 mg/L). This gives reason to believe that the equal molar dose was not 
sufficient, and under dosing occurred. It can also be seen on above plots that the trend lines for 
the two sets of coagulants have slightly different shapes. For both trend lines generated form the 
equal molar dosing experiments, the rate at which the TMP increases was elevated, as the 
induced membrane fouling occurred sooner.  After the first day, the TMPs were approximately 
9.0 and 7.0 for SP 70 and SP respectively, compared with 6.0 and 5.0 for the optimal dose plots. 
Again, this was attributed to the fact that a higher concentration of suspended solids remained 
un-coagulated during the equal molar trials, and therefore occupied the adsorption sites on the 
membrane surface and inside the pores, causing a more severe fouling effect. There may also 
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have been less DOM coagulated if the coagulant dose was not sufficient to meet the entire 
‘coagulant demand’ of the organic matter. 
 
Figure 5-5 shows the results obtained using the two conventional coagulants. Similar to the 
results shown for the pre-hydrolyzed coagulant, the equal molar trend lines for both alum and 
ferric chloride had elevated rates of TMP change, as well final TMP values, substantially higher 























No coagulant Alum (EM) Alum (optimal) FC (EM) FC (optimal)
 
Figure 5-5: Grand River membrane treatment summary                                                 
(Alum and ferric chloride - equal molar vs. optimal dose) 
 
It was interesting to observe the fact that alum proved to be the most efficient coagulant at 
reducing membrane fouling at an optimum dose, but when the equal molar dose was employed, 
alum showed the worst results. These results were most likely attributed to over-dosing, as the 
equal molar dose was 17 mg/L higher than the optimal dose. Therefore, a re-stabilization of the 
particles in the raw water most likely occurred. In addition, the production of more floc from the 
elevated dose would have led to more in suspension. These trends were seen with the jar test 
trials results (Chapter 4). When a smaller portion of the solids in the raw water are flocculated, 
more adsorb onto the surface and/or inside the pores of the membrane fibres. Table 5-2 presents 
a concise summary of the TOC and turbidity removal data for these sets of membrane trials. As 
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with the optimal dose trials, samples were taken from the membrane system on a daily basis in 
duplicate.  
 






removed by UF 
membrane
Alum 35-45% / 40-50% 5-10% / 99%
Ferric chloride 40-45% / 50-60% 5-10% / 99%
PACl (SP) 35-45% / 55-65% 5-10% / 99%
PACl (SP 70) 25-35% / 50-60% 5-10% / 99%
 
 
The UF membrane behaved the same during the equal molar trials as for the optimal dose trials, 
with 5-10 % and 99 % removals observed for TOC and turbidity respectively. The 
coagulation/flocculation step removals were lower for all four coagulants. As previously 
mentioned, this was attributed to the over dosing of alum, and under-dosing of the three other 
coagulants. The difference for alum was the most extreme, having the worse membrane fouling 
results; this was coupled with TOC removals that were 15 % lower. As noted previously, lower 
TOC removals could have also contributed to more fouling, in addition to the effect from higher 
inorganic turbidity.  
 
5.3 Membrane Trials Using Lake Ontario Water 
Figure 5-6 shows a summary of the Lake Ontario membrane trials conducted with the optimal 
coagulant doses (for that water) of all four coagulants. These doses were determined during the 
jar test trials (Chapter 4): 15 mg/L, 20 mg/L, 15 mg/L and 20 mg/L for alum, ferric chloride, SP 



























No pre-treatment Alum at 15 mg/L FC at 20 mg/L SP 70 at 20 mg/L SP at 15 mg/L
Difference of 1.3 psi
 
Figure 5-6: Lake Ontario membrane treatment summary                                            
(optimal coagulant doses vs. raw water) 
 
The two pre-hydrolyzed coagulants performed the best at reducing the rate at which the TMP 
increased, with a final TMP of 5 and 4.9 psi for SP and SP 70 respectively, as compared to the 
raw water membrane trial, which yielded a final TMP of 6.2 psi. These values represented a 20 
% and 22 % reduction in final TMP respectively using the two coagulants. The two other 
coagulants yielded TMP reductions of 12 %, 15 % for alum and ferric chloride respectively.  
 
It is worth noting here, that the rates of TMP increases for these sets of trials cannot be compared 
to those obtained with the Grand River membrane trials. Lake Ontario’s water quality was much 
better, with an average TOC concentration around 2.5 mg/L, coupled with a raw water turbidity 
of only 0.5 NTU.  
 
Table 5-3 presents a concise summary of the TOC and turbidity removal data for the Lake 
Ontario water membrane trials. Sample collection was conducted in the same manner as for all 
other trials.  
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removed by UF 
membrane
Alum 30-35% / 30-40% 5-10% / 80-90%
PACl (SP 70) 15-20% / 30-40% 5-10% / 80-90%
Ferric chloride 25-30% / 5-10% 5-10% / 80-90%
PACl (SP) 20-25% / 50-60% 5-10% / 80-90%
 
 
The UF membrane behaved slightly worse during the Lake Ontario water trials. The turbidity 
removal was observed to be between 80-90 %, as compared to the Grand River trials, where 99 
% removal was consistently seen. This was attributed to the sizeable difference between the raw 
water turbidities, which were always consistently a magnitude apart. The membranes permeate 
quality consistently produced water below 0.1 NTU, but with the Lake Ontario raw water 
turbidity hovering between 0.5-6 NTU, the percentage removal was lower. As with the Grand 
River trials, this reinforced the fact that the membrane effluent quality was not a strong function 
of the raw water turbidity. The TOC percentage removals were similar for the two raw water 
sources, at 5-10 % efficiency. 
 
The coagulation/flocculation step removals were also observed to be on average lower for trials 
conduced with Lake Ontario water as compared to Grand River water. Lake Ontario raw water 
TOC levels were consistently below 2.8 mg/L, coupled with a DOC/TOC ratio well over 90 %. 
As is often the case with raw water that contains very low TOC concentrations, the fraction of 
TOC removed was decreased (Shrive et al., 1999). This trend was seen in the jar test trials, for 
both the raw water and synthetic water cocktail experiments. With these sets of water conditions, 
a longer hydraulic retention time in the floc tank would have most likely not had a positive effect 
on the TOC removal. Coagulation reactions occur almost instantaneously, and as long as there is 
sufficient time for flocculation to occur, which in this case there was, increasing the size of the 
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floc tank would not have made a difference in the TOC removal results. Moreover, the nature of 
the NOM in the Lake Ontario water was likely different than the Grand River water. Although 
both included a wide range of humic and non-humic macro-molecular organic compounds, 
which can have different effects with the coagulant, the Grand River water would be expected to 
contain a “younger” TOC, with a higher fraction of non-humic material due to wastewater 
effluents. 
 
5.4 Comparison of Lake Ontario and Grand River Results 
The following table shows a concise summary of the TMP reductions that were observed for the 
two sets of optimal dose trials conducted, with Grand River and Lake Ontario water. It is worth 
noting here, that the rates of TMP increases for these sets of trials cannot be compared to those 
obtained with the Grand River membrane trials. Lake Ontario’s water quality was much better, 
with an average TOC concentration around 2.5 mg/L, coupled with a raw water turbidity of only 
0.5 NTU, as compared to the Grand River water, which had a TOC concentration over 6 mg/L, 
and a turbidity of 8.0 NTU. 
 






PACl (SP) 46% 20%







As it is clearly seen, the TMP reductions were substantially larger during the Grand River trials, 
for all four coagulants. This was expected given the contrast in TOC and turbidity levels.  One 
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interesting point to note was the fact that alum performed best for the Grand River trials, and 
worse for the trials conducted with Lake Ontario water.  This reinforces the fact that the type of 
NOM that exists in the two source waters is quite different, because if their NOM composition 
was similar, one would expect to observe similar removal trends. 
 
5.5 Membrane Trials with Modified Parameters 
The following section describes the results obtained from the series of membrane trials 
performed with modified raw water pH and mixing intensities in the flocculation tank. The trials 
were conducted with Grand River water only, in order to determine the effect of pH and mixing 
intensity had on membrane fouling and overall water quality. There were a total of 8 trials 
conducted: the first four trials were performed with the raw water pH reduced to 5.5 for the three 
aluminum based coagulants, and 5.0 for ferric chloride, while the second half of the trials were 
conducted with a raised mixing intensity from the 30 rpm (base-line) to 45 rpm. Optimal doses 
were utilized in both cases, and datum related to TMP and water qualities were recorded in the 
same manner. 
5.5.1 Modified raw water pH 
Figure 5-7 shows a summary of the Grand River membrane trials conducted with a reduced raw 
water pH, coupled with optimal coagulant doses of all four coagulants. As previously mentioned, 
the raw water was spiked with reagent grade hydrochloric acid (VWR International, Mississauga, 
ON) to reduce the pH. These doses were pre-determined during the jar test trials (Chapter 4): 30 
mg/L, 45 mg/L, 40 mg/L and 50 mg/L for alum, ferric chloride, SP and SP 70, respectively. The 
reduced pH levels utilized for all four coagulants represented the level that induced optimal 
coagulation for TOC removal (Sharp et al., 2006, Randtke, 1988).  The spiked raw water 
maintained a reasonably constant pH throughout the 3-day trials, with a pH increase observed of 


























No coagulant Alum at 30 mg/L FC at 45 mg/L SP 70 at 50 mg/L SP at 40 mg/L
Difference of 5.8 psi
 
Figure 5-7: Grand River membrane treatment summary                                        
(Aluminum based @ pH 5.5, Iron based @ pH 5) 
 
Similar to the trials conducted with optimal coagulant doses without pH adjustment, alum 
performed the best at reducing the membrane fouling, with a final TMP of 4.8 psi, as compared 
to the alum trial without pH adjustment (Figure 5-2), which yielded a final TMP of 5.3 psi, 
representing a 4 % reduction in overall TMP as compared to the optimal dose trials without pH 
adjustment. The three other coagulants yielded TMP reductions of 44 %, 46 % and 40 %, 
representing a reduction of 5 %, 6 % and 6 % as compared to the trials without pH adjustment 
for ferric chloride SP and SP 70 respectively. In the literature, several membrane treatment 
studies have been conducted with pH reduced raw water, and membrane filtration/performance 
was always better (e.g. Howe and Clark, 2006). 
 
 In all four cases, the reduced pH levels showed a consistent improvement over the base-line 
trials. A possible reason for the improvement was a stronger floc formation caused by the 
optimal conditions induced with the reduced pH, and more complete coagulation reaction. A 
stronger floc formation was less affected by the stirring motion of the mixing propeller, and 
therefore a larger fraction of the flocculated NOM settled out of solution, resulting in a reduced 
fouling effect. A comparison of the TOC removal results showed that there was an increase of 5 
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%, 2 %, 1 % and 2 % for alum, ferric chloride, SP and SP 70 for the trials with pH adjustment as 
compared to the membrane trials conducted with optimal coagulant doses without pH adjustment 
 
Although not shown in the plots directly, the addition of a coagulant to the Grand River water 
with a reduced pH enhanced the adsorption and charge neutralization that was displayed in the 
jar test trials conducted with raw Grand River water. The increased TOC removals observed 
during these trials were attributed to the enhanced adsorption and charge neutralization. 
Moreover, this was the primary purpose of reducing the pH, in order to increase the TOC 
removal during the coagulation step. Under conditions of optimal pH, sweep floc coagulation has 
less of an effect, as charge neutralization tends to dominate. The specific mechanisms of the 
coagulant at a reduced pH are much less understood, due to a paucity of knowledge regarding 
which NOM species were are present in any given raw water source, not just the Grand River 
and Lake Ontario (Sharp et al., 2006). It is also worth noting here that at elevated pH values 
(above 7), hydroxyl ions are able to successfully compete with NOM for available metal 
coagulant ions, reducing the amount of NOM that is coagulated (Randtke, 1988). 
 
The four trend lines showed similar shapes. As compared to the base-line optimal dose trials, 
these plots did not show signs of an increased slop at the beginning of the trial, but rather the 
sloped maintained a constant value over the first two days, levelling of a small amount at the 
end. The difference in the shape of the plots was attributed to the efficiency of the respective 
coagulants that performed under optimal pH conditions. As with the raw water trials that showed 
a steep slope (Figure 5-1), followed by the base-line trials that showed a much less extreme 
slope, an idea pre-treatment system would yield a TMP trend line that has a consistently 
increasing slope, similar to the ones showed in Figure 5-7 above. Although the fouling and water 
quality results were improved for the membrane trials with a modified raw water pH, the cost of 
the overall process is a factor that would have to be heavily considered in the design of any full 
scale operation.  The benefit of operating at a reduced pH may in some cases by outweighed by 
the cost of chemicals required to first reduce the pH, and then raise the pH back up to potable 
standards at the end of the process.  Depending on the finished water quality requirements, the 




5.5.2 Modified mixing intensity in flocculation tank 
Figure 5-8 shows a summary of the Grand River membrane trials conducted with a modified 
mixing intensity in the flocculation tank, coupled with optimal coagulant doses of all four 
coagulants. These doses were determined during the jar test trials (Chapter 4): 30 mg/L, 45 
mg/L, 40 mg/L and 50 mg/L for alum, ferric chloride, SP and SP 70 respectively. The mixing 

























No coagulant Alum at 30 mg/L FC at 45 mg/L SP 70 at 50 mg/L SP at 40 mg/L
Difference of 2.9 psi
 
Figure 5-8: Grand River membrane treatment summary                                                       
(45 rpm mixing intensity in flocculation tank) 
 
All four coagulants showed increased TMP values across the 3-day trial, as compared to the 
base-line trials conducted with optimal coagulant doses. Table 5-5 provides a concise summary 
of the results obtained from the membrane trials conducted with modified mixing intensities.  
The first two columns show the individual TMP reduction results 
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Alum performed the best at reducing the membrane fouling, reducing the final TMP from 12.5 to 
8.4 psi, a reduction of 33 %. Having said this, in comparison to the base-line alum trial, an 
increase of 24 % TMP was observed. Similar results were observed for the other three trials, with 
reductions of 32 %, 28 % and 23 % for ferric chloride, SP and SP 70 respectively. Once more, 
these reductions were substantial, but when compared to the base-line trials, elevated TMP 
results were observed for all three coagulants: 12 %, 18 % and 17 % for ferric chloride, SP and 
SP 70 respectively. These results were heavily attributed to the design of the bench-scale 
membrane system.  
 
The flocculation tank had a cylindrical shape, approximately 1.5L in size, and a 4” (0.102m) 
diameter. The 2.5” (0.064m) diameter mixing blade was located 2” (0.051) above the bottom of 
the tank. During the base-line optimal dose trials (30 rpm), a particle gradient developed in the 
flocculation tank. One could visually observe the accumulation of flocs on the bottom of the 
tank. At the top of the tank, where the effluent spout was located, there were very few flocs, 
hence the system behaved essentially as a settled water membrane treatment system. The 
flocculation tank was emptied every 24 h during the 3-day baseline trials, and each time, there 
was a thick layer of flocs that had accumulated at the bottom of the tank; this trend was observed 
for all four coagulants.  
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In contrast, during the trials conducted with the elevated mixing intensities, the solids gradient 
and the accumulation of particles on the bottom of the tank was not clearly observed, as the 
faster rotating blade caused the particles to re-suspend, and in doing so, a much larger portion of 
the flocs transferred over to the membrane tank. These observations, coupled with the increased 
TMP that occurred under conditions of elevated mixing rates, supported the hypothesis that 
suspended particles did in fact contribute to the membrane fouling (Lee et al., 2000); although 
there was definitely a substantial concentration of DOC that existed in solution, the results 
showed hat the DOC concentration decreased because of the elevated mixing intensity. The DOC 
concentration was decreased by 6 %, 11 %, 17 % and 12 % for alum, ferric chloride, SP and SP 
70 respectively. These conclusions also demonstrate that DOM by itself does not cause 
membrane fouling, but rather it is a combination of the dissolved and suspended particles that 
creates the overall effect (Howe and Clark, 2002b).  
 
5.6 Membrane Trials with Half Optimal Coagulant Dose 
The final round of experiments involved utilizing coagulant doses that were half the 
concentration of optimal doses used during the base-line trials. These doses corresponded to 15 
mg/L and 20 mg/L for alum and SP respectively. Figure 5-9 shows a plot comparing the two sets 
of trials (optimal dose and half optimal dose). As a reminder, these doses were tested to observe 
the difference in TOC removal and membrane fouling when the coagulants were severely under-
dosed, and were performed because of indications that such lower doses were used at least 

























No coagulant Alum (half dose) SP (half dose) Alum (optimal) SP (optimal)
 
Figure 5-9: Grand River membrane treatment summary                                                 
(Alum and SP – half optimal dose vs. optimal dose) 
 
The two trials conducted with half the optimal dose trials yielded TMP reductions of 22 % and 
17 % for alum and SP respectively.  Although these represented substantial reduction, it clearly 
evident from the plots above, that the trials conducted with optimal coagulants doses provided 
much better results. Comparing the two sets directly, the trials conducted with half the optimal 
dose proved to be superior in terms of overall TMP reduction, yielding results that were 34 % 
and 27 % lower for alum and SP respectively. These results were expected, as these sets of trials 
simply did not provide a sufficient dose of coagulant, to accommodate the high concentration of 
solids in the raw water. 
 
Visually, it was clear that that the floc formation was not as strong during these sets of trials; the 
water flowing into the membrane tank maintained a brownish colour, with an average turbidity 
of 5.2 and 5.7 NTU for alum and SP respectively, as compared to the base-line trials which had 
values 2.2 and 2.8 NTU for the same coagulant water combination. The membrane effluent 
turbidity values were not affected; as previously mentioned, the membrane effluent turbidity was 




Flocculated water samples were not analyzed for TOC during the base-line optimal dose trials. 
Having said this, the TOC removals for the entire system were quantified for both sets of trials, 
and these results reinforce the fact that the optimal doses for TOC removal determined during the 
jar test trials were in fact suitable for bench-scale membrane system design. The TOC removals 
for the half optimal dose trials were 42 % and 31 % for alum and SP respectively, as compared to 
59 % and 52 % for the same coagulants at optimal doses, representing a decrease of 71 % and 60 
% for the alum and SP respectively. These results were attributed entirely to the under-dosing of 
both coagulants. Shrive et al. (1999) discovered similar trends: when a PACl product and alum 
were under-dosed, there was a sharp decline in flux across the surface of a UF membrane.  
 
These under-dosing trends corresponded very well with the results obtained while conducting the 
jar test trials. At low aluminium doses, these two coagulants yielded very similar results, with 
minimal TOC removals observed at doses of 15 mg/L and 20 mg/L for alum and SP respectively. 
In both cases the jar test trials and the membrane pre-treatment experiments, the provided 
coagulant doses was simply not large enough accommodate the particle and TOC concentration 
in the raw water, therefore a large portion of the NOM remained suspended in the water. 
 
5.7 NOM Fractionation Analysis 
NOM fractionation was a very innovative part of this research, since by quantifying the different 
sized fractions of NOM that existed in the Grand River water, the fractionation furthered the 
understanding of what fractions of the NOM contribute to fouling most. This section presents a 
series of plots that detail the fractionation of raw and treated Grand River water. The 
fractionation of any water sample can be based on a number of characteristics, but the most 
useful method for this research project was to fraction it in terms of its molecular weight cut off 
(MWCO). Each of figures categorizes the five fraction ranges (x-axis), and presents a TOC 
concentration corresponding to each of the five ranges (y-axis). As discussed in Chapter 3, this  
fractionation was accomplished using a series of UF filtration filters (Millipore Inc., Billerica, 
MA) with different molecular weight cut offs (MWCO) to sequentially separate the water into a 
series of molecular weight fractions 
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5.7.1 Raw water 
Figure 5-10 shows a histogram that details the results obtained from the Grand River raw water 
fraction conducted in two separate time periods, one in July, and on in August 2006. Along the 
x-axis, the first set of bars describe the whole filtered results, which was simply a raw water 
sample, filtered through a 0.45 µm filter to remove any particulate matter. This was included in 
the plot to serve as a base-line concentration, from which all subsequent fractions were extracted. 
It is also worth nothing here that all fractionations were performed with whole filtered water; 
given that the UF fractionation discs would foul extremely quickly if exposed to a large 
concentration of suspended solids. The pre-filtration step ensured that the filter discs were only 
exposed to dissolved organic matter. The DOC concentration in the treated water did not vary a 
great deal; therefore results using whole filtered water were not affected by the variation in the 






































As clearly seen in the above figure, the distribution of the NOM across the five MWCO’s did not 
vary a great deal, with the exception of the ‘larger than 30K’ range, which showed an elevated 
level of TOC as compared to the other four other distribution categories. Having said this, the 
‘larger than 30K’ distribution differed in the fact that it contained only one limit, therefore 
including all NOM larger than 30K, as opposed to the true range distributions, which had two 
fixed boundaries. Scanning across the four other categories, the TOC concentrations ranged from 
0.25 to 0.80 mg/L, with no distinct trend as to which of the four contained the most TOC. The 
fractionation work conducted in August, 2006, had a higher concentration in the ‘10K-30K’ 
range, but had a lower concentration in the ‘1K-30K’ range. Having said this, it was very 
difficult to interpret the results obtained from the raw water fractionation, as there were several 
discrepancies between the two sets of experiments that made it difficult to make accurate 
conclusions. One major issue that arose during the experiments was the fact that there was 
construction going on in the vicinity of the lab-bench, which affected the concentration of dust 
particles in the air, and therefore could have had a direct effect on the fractionation results.  
Another reason why the two sets of experiments are difficult to compare is because there was no 
replication performed for these sets of experiments, and without replication one cannot access 
reproducibility. The two sets of fractionation should be performed on the same day, using the 
exact same equipment and fractionation discus, to eliminate as many uncontrollable factors as 
possible.  
 
One conclusion that was clearly evident was the fact that there existed a wide variety of NOM in 
the raw water, with a large variation in nominal molecular weights. There was a significant TOC 
concentration in every one of the ranges; therefore proving that the Grand River NOM ranges 
widely in size, found in all of five of the molecular weight distributions. Even though the 
nominal pore size of the UF membrane was in the area of 400,000 Da, the larger particles still 
may have had a tendency of forming a cake layer on the surface of the membrane. The smaller 
particles would therefore be more inclined to adsorb inside the pores of the membrane, causing 
the diameter of the pores to be restricted, and subsequently increase the TMP over a time.  
 
 100 
5.7.2 Optimal coagulant dose 
In order to determine which of the NOM fractions contributed to membrane fouling most, a 
fractionation study was performed on Grand River water treated with each of the four coagulants 
during the base-line optimal dose trials. Therefore, four separate membrane effluent water 
samples were fractionated: these samples had been treated with 30 mg/L, 45 mg/L, 40 mg/L and 
50 mg/L for alum, ferric chloride, SP and SP 70 respectively. Figure 5-11 shows a break-down 
of the results obtained from the fractionation experiments performed with these four samples. 
The raw water results are shown in the figure as well, so to provide a mode of comparison. The 
results are plotted as an average of the two fractionations performed with the raw water. The 
results for each of the other four coagulants are shown individually. 
 




























Raw SP Ferric chloride Alum SP 70
 
Figure 5-11: Treated Grand River water MWCO distribution                                        
(Optimal coagulant dose) 
 
The whole filtered results for the four coagulants were recorded as the DOC contained in the 
membrane effluent corresponding to the specific coagulant, filtered through a 0.45 µm filter. As 
it can clearly be seen, the largest difference between the raw water and the four treated water can 
be seen in the ‘whole filtered’ category. The raw water had a TOC concentration hovering 
around 5.5 mg/L, while the highest treated water concentration was 3.4 mg/L. 
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Looking across the four fraction categories, there were two distinct trends observed between the 
raw and treated waters. A TOC concentration difference of at least 0.5 mg/L and 0.33 mg/L was 
observed between the raw water and the four coagulants for the ‘larger than 30K’ and ‘1K-3K’ 
categories respectively. This indicated that the molecules within these MWCO categories were in 
fact removed by the membrane pre-treatment system. Coagulation conditions that are effective at 
removing TOC are also known to be effective at removing the fraction responsible for membrane 
fouling (Howe and Clark, 2002b). Having said this, it cannot be said with certainty that it was 
these molecules that contributed to the membrane fouling, as they could have simply been 
removed by the coagulation pre-treatment process, and never even been exposed to the surface of 
the membrane. So therefore, the results observed in this case confirm that the system removed a 
large fraction of molecules that were in the ‘larger than 30K’ and ‘1K-3K’ range, but further 
fractionation experiments would have to be performed on both treated and flocculated waters, to 
isolated the source of both the fouling and NOM removals. Collins et al., (1996) used a UF 
fractionation method, to determine the apparent MW of humic substances, and one observation 
that came up was that distortion of the organic molecules under shear in the UF discs allowed 
passage of larger molecules, than what was expected, based on the nominal pore size of the given 
fractionation membrane. The fractionation experiments conducted throughout this project could 
have definitely been affected by this phenomenon, as in several cases, the TOC concentration 
from one category to the next did not decrease a great deal. 
 
Given the complex nature of interactions involved amongst the wide variety of NOM 
components, it was not surprising to observe results that were not distinctly conclusive. Several 
others found little correlation between the apparent molecular weights (AMW) of NOM 
determined by UF fractionation (Leenheer et al., 1995, Newcombe and Drikas, 2006). This 
simply reinforces the notion that in order to obtain more concrete results, replication of the 
experiments with duplicate sampling methods is required. Simply comparing two individual sets 
of experiments does not offer a great deal of confidence. 
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5.7.3 Optimal coagulant dose with modified raw water pH 
Figure 5-12 shows a summary of the fractionation experiments conducted with treated Grand 
River water samples, taken from the trials conducted with a reduced raw water pH, coupled with 
optimal coagulant doses of all four coagulants.  
 
Treated Grand River Water MWCO Distribution



























Raw SP Ferric chloride Alum SP 70
 
Figure 5-12: Treated Grand River water MWCO distribution                                          
(Reduced raw water pH) 
 
The results for these sets of fractionation experiments did not differ a great deal from those 
conducted with samples taken from the base-line optimal dose trials. As expected, the trials at a 
reduced pH yielded treated waters that had lower TOC concentrations, which can be seen across 
all four categories when comparing the two figures. This was attributed to the optimized 
adsorption and charge neutralization conditions that were induced by the reduced pH. As 
previously mentioned, the jar test trials also showed trends that gave way to adsorption and 
charge neutralization as the dominant mechanism, as opposed to sweep flocculation. 
 
One slight difference that was noted was the fact that the ‘larger than 30K’ category showed a 
decreased TOC concentration for the pH reduced trials, as compared to the base-line optimal 
dose fractionation results. This trend was seen for all four coagulants, giving rise to the notion 
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the removal of this fraction was altered by the reduced pH, and further investigations would have 
to be conducted to make more accurate conclusions. 
5.7.4 Water fractionation comparison 
Figure 5-13 provides a summary of fractionation experiments conducted throughout the duration 
of this project. The raw water bars were generated from the summary of the two trials conducted 
with raw water, while the other two plots were created by taking an average of the four 
coagulants results for both the base-line optimal dose trials and the trials with reduced raw water 
pH. This plot provides a better visual interpretation of the different effect the coagulant had 
based on a modified pH. As previously mentioned, one can see a substantial amount of removal 
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Figure 5-13: Raw vs. Treated Grand River water MWCO distribution                      
(Optimal coagulant dose) 
 
Although this could imply that the majority of NOM removed existed in these two ranges, and 
that the potential for these two fractions to cause the membrane fouling was increased, this 
cannot be said with confidence, as these two fractions could have been removed in the 
coagulation step, and never even reached the membrane surface. 
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5.8 Residual Metals Analysis Results 
Throughout the duration of all the membrane trials, the treated water was sampled on a daily 
basis, and analyzed for residual aluminum and iron. Figure 5-14 provides a summary of the 
residual metal analysis data for the trials conducted with alum, SP and SP 70, which were 
aluminum based coagulants. Ferric chloride was the only iron based coagulant. The ferric 
chloride results were not included in the figure because iron was not detected in any of the 
permeate samples. The detection limit for all the iron samples was 0.05 mg/L, and 0.01 mg/L for 
the aluminum samples. The MOE Drinking Water Standards objectives and Guidelines (MOE, 
2003) specified that both these metals were classified as aesthetic objectives, which means that 
these elements may impair the taste, odour and colour of drinking water, but are not considered 
to have a significantly harmful effect to humans. Having said this, there still exists room for 
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Figure 5-14: Treated water residual aluminum analysis summary 
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The aesthetic objective for iron, set by appearance effects in drinking water is 0.3 mg/L. 
Excessive levels of iron in drinking water supplies is seen with a brownish colour. It may 
produce a bitter, astringent taste in water and beverages; and the precipitation of iron can also 
promote the growth of iron bacteria in water mains and service pipes. Iron based coagulants such 
as ferric chloride, the one used in this project, is known to be highly effective in treatment 
processes at removing particles from water and leaving very little residual iron in the treated 
water (MOE, 2003). This was proven to be true throughout the duration of this project, as all of 
the analyses pertaining to trials conducted with ferric chloride yielded ‘results that were below 
the detection limit (0.05 mg/L) established by the laboratory that conducted the work. Cleary, the 
residual iron concentration coming as a result of the use of ferric chloride as a pre-treatment to 
membrane bares no concern in the overall process design, as even the equal molar trial yielded 
results that were below the detection limit. 
 
The results obtained for the residual aluminum analysis were not as convincing as the iron 
results, as there were several results over the limit legal limit established by the MOE. The 
aluminum found in the treated water was due to the presence of aluminum left over from use of 
the coagulant. Ideally, optimization of the treatment should be applied to reduce this residual 
aluminum to under the aesthetically operational guideline of 0.1 mg/L. High residual aluminum 
can cause coating of pipes in a distribution system resulting in increased energy requirements for 
pumping, interferences with certain industrial processes and flocculation in the distribution 
system (MOE, 2003). 
 
There were a total of six membrane trials that yielded average results that were above the 
acceptable limit. Trials conducted with the PACl products yielded exceedances for both the base-
line optimal dose trials, and the equal molar trials. The SP 70 coagulant also showed an 
exceedance for the trial conducted with a reduced raw water pH as well. The elevated residual 
metal concentrations observed with PACl products was not surprising, as they coagulants have a 
reduced ability of performing the hydrolysis reactions to produce hydrogen ions, as some of this 
required acid was neutralized with a base during the manufacturing stage. With exception of the 
analysis performed on the trials conduct with SP and SP 70, the only other result that stood out 
was the equal molar dosing trial conducted with alum. This was expected; given the fact that the 
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equal molar dose was 17 mg/L higher than the optimal dose of 30 mg/L. The excess coagulant 
concentration did not participate in the coagulation flocculation step, and therefore remained in 
solution and passed through the membrane pores, remaining in the permeate stream. This result 
again, reinforced the fact that the optimal doses determined with the jar test trials were in fact 
suitable for this membrane filtration experimental design. Figure 5-15 shows the standard 
solubility diagram for the aluminum (Al3+) ion. As can be seen, the operating range for 
aluminum hydroxide precipitation is in a pH range of 5.5 to 7.7, with a minimum solubility 
occurring at a pH of about 6.2 (MWH, 2005). Although temperature was held reasonably 
constant at room temperature, it is worth noting that the point of minimum solubility for 
aluminum shifts with temperature, which has a significant impact on full scale plan design where 




Figure 5-15: Standard solubility diagram for Al(III), (MWH, 2005) 
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According to the standard solubility diagram, the solubility of the aluminum decreases with an 
increasing pH level. Therefore as previously as mentioned, the residual metal exceedances 
observed with the PACl coagulants was not surprising, given that the resultant pH was 0.5 units 
higher on average for trials as compared to the trials conducted with the two conventional 
coagulants (alum and ferric chloride).  
 
5.9 Total Suspended Solids Analysis Results 
Table 5-6 provides a summary of the TSS analysis results for two sets of trials conducted using 
Grand River water, with modified raw water pH and mixing intensity in the flocculation tank. As 
a reminder, both sets of trials were conducted with optimal coagulant doses. The raw water was 
sampled prior to entering the flocculation tank, the treated water was sampled at the membrane 
effluent point, and the floc water was sample directly form the flocculation tank. 
 
Table 5-6: Treated water total suspended solids analysis summary 
Raw Treated Floc Raw Treated Floc
76.2 0.30 73.1 80.5 0.30 69.8
72.8 0.30 73.0 72.5 0.40 81.0
78.4 0.30 70.8 69.2 0.30 53.1
81.1 0.40 75.5 73.5 0.30 86.2
Total Suspended Solids (TSS) mg/L
Modified pH Modified mixing rate
PACl (SP) at 40 mg/L 
Grand River 
Alum at 30 mg/L
FC at 45 mg/L 
PACl (SP70) at 50 mg/L
 
 
As clearly seen in the above table, there were no substantial differences observed in the results 
between the two sets of trials. All raw water TSS concentrations ranged between 70-82 mg/L, 
with the results from the treated waters showing 99 % TSS removal. All of the treated water TSS 
concentrations were between 0.3-0.4 mg/L, reinforcing the fact that the UF membrane was able 
to maintain a consistent permeate quality, with a very low turbidity. The flocculated water TSS 
concentrations varied slightly between coagulants. This was less attributed to the coagulants, and 
more so to the elevated mixing intensities and sampling method. The water was sampled by 
collecting the tank effluent (membrane tank influent), and therefore the concentration of solids 
was not consistent, and a representative sample was not obtained each time. This coupled with 
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the fact that the elevated mixing rates caused the flocs in the tank to re-suspend, and therefore 
making it difficult to compare solids concentrations under different mixing conditions. 
Nevertheless, the most important observation was that the membrane was very efficient at 
removing the TSS, which the results confirmed, across all four coagulants. 
 
5.10 Conductivity Analysis Results 
Table 5-7 provides a summary of the conductivity analysis results for two sets of trials conducted 
using Grand River water, with modified raw water pH and mixing intensity in the flocculation 
tank.  
 
Table 5-7: Treated water conductivity analysis summary 
Raw Treated Floc Raw Treated Floc
514 509 589 515 521 609
511 507 599 514 518 610
512 510 594 519 519 599
518 511 594 520 520 603
Conductivity (µS)
Modified pH Modified mixing rate
Grand River 
Alum at 30 mg/L
FC at 45 mg/L 
PACl (SP70) at 50 mg/L
PACl (SP) at 40 mg/L  
 
Conductivity in water is affected by the presence of inorganic dissolved solids such as chloride, 
nitrate, sulfate, phosphate anions and also, sodium, magnesium, calcium, iron, and aluminum 
cations. The organics contained in the Grand River do not conduct electrical current very well 
and therefore have a very low conductivity, contributing negligibly to the overall conductivity. 
The variations that do occur in the Grand River are primarily seasonal, because in the winter 
months much more of the flow is groundwater base flow. Having said this, the results in the 
above table make sense, as there were no clear trends observed, with the exception of the 
flocculated water having an elevated conductivity by approximately 18-20 %, induced by the 
addition of the metal coagulants, which contributed to the conductivity. All four sets of trials 
showed very similar results; the flocculated water conductivity hovered between 589-610 µS, 
subsequently reduced down to a level between 507-521 µS. This reduction in conductivity was 
attributed to the coagulant, which precipitated, and was removed during the filtration process. So 
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the main conclusion that came out of this work was the fact that the elevated water conductivities 
were not affected by varying the coagulant type, which was expected, as the compounds that 
contribute to conductivity, are not a function of the varying coagulation conditions. With raw 
waters with a lower conductivity (below 200 µS), the type of coagulant could make a difference, 
particularly if different coagulant doses were used. 
 
5.11 Alternative Methods of Interpreting Data 
All of the data in this chapter related to the rate of change of TMP has been plotted against time 
on the x-axis. Every plot was shown as the difference in pressure across the membrane surface 
over a 3-day period. Figure 5-16 and 5-17 provide an alternative approach to the conventional 
way of presenting the TMP data. These two plots are essentially linear transformations of Figure 
5-2, which was the plot showing results obtained from the membrane trials conducted with the 
optimal coagulant doses using raw Grand River water. Figure 5-16 shows the TMP data plotted 
against a cumulative volume of water treated per m2 of membrane surface area, while Figure 5-
17 shows a plot of the pressure data against a cumulative mass of carbon delivered to the 
membrane surface. It was assumed that the volume of water treated by the membrane was 45 
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No coagulant Alum at 30 mg/L FC at 45 mg/L SP 70 at 50 mg/L SP at 40 mg/L
Difference of 5 psi
 
Figure 5-16: Grand River membrane treatment summary                                                
(TMP vs. volume of water treated by the membrane) 
 
Using this alternative method of plotting the TMP has the potential to provide very useful results 
and/or trends to water treatment plant operators and researchers alike. Instead of simply drawing 
conclusions on how far into the 3-day trial certain trends were observed, one is able to quantify 
the volume of water cumulatively treated at that time. For example, in Figure 5-16 it was 
observed that after approximately 2100 L of water was treated/m2, the TMP stabilized for the 
remainder of the 3-day trial. This volume of water could now be used as a base-line comparison 
for other process optimization experiments. One could observe what volume of water it would 
take for the TMP to stabilize based on different parameter settings, therefore establishing a 
different approach to assessing membrane fouling. For plant operators, this approach could 
provide assistance when trying to establish an acceptable limit for the TMP on any full scale 
system. The need to maximize the amount of water treated before reaching a set TMP point 
would be very important in the overall process design. 
 
Figure 5-17 provides a slightly different approach to analyzing the TMP data. This plot shows 
TMP data plotted against a cumulative mass of carbon delivered to the membrane surface. 
Similarly, this approach could prove very beneficial for plant operators and research; but in a 
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No coagulant Alum at 30 mg/L FC at 45 mg/L SP 70 at 50 mg/L SP at 40 mg/L
Difference of 5 psi
 
Figure 5-17: Grand River membrane treatment summary                                                  
(TMP vs. mass of carbon delivered to the membrane) 
 
In this figure, it was assumed that incoming water had an average DOC concentration of 5 mg/L, 
which corresponded to the raw Grand River water concentration. The raw water did not have any 
appreciable variations in DOC concentration. Again, looking at the point where the TMP 
stabilized, there was approximately 12.0 g of carbon treated by the membrane. Plant operators, 
could utilize this information when establishing thresholds on TMP. If a raw water source with a 
given water quality takes approximately 12.0 of carbon to reach a TMP pressure of 12 psi, then 
an increased in TOC concentrations would result in a higher pressure value, corresponding to an 
increased fouling rate. If it was therefore known that through a given season, the DOC 
concentration in the raw water drops a known amount, a plant operator would be able to 
approximate how much more water can be treated until the threshold pressure was reached. 
Changes in turbidity reaching the membrane would also play a role in a similar manner, as one 
could determine a threshold on TMP, based on the turbidity level in the in-coming raw water 
stream. The same method of data presentation is shown in Figure 5-18, for the five membrane 
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No pre-treatment Alum at 15 mg/L FC at 20 mg/L SP 70 at 20 mg/L SP at 15 mg/L
Difference of 1.3 psi
 
Figure 5-18: Lake Ontario membrane treatment summary                                                  
(TMP vs. mass of carbon delivered to the membrane) 
 
Similar with the Lake Ontario membrane trials, this form of data presentation would be very 
useful in a full scale design. It was assumed that the incoming water had an average DOC 
concentration of 2.1 mg/L, which corresponded to the raw Lake Ontario water concentration. 
Although Figure 5-17 and 5-18 present results for two different water sources, one can drawn 
useful comparisons from the plots.  In Figure 5-18, the TMP does not really stabilize over the 
duration of the 3-day trial, as compared to Grand River trials that stabilize at a specific carbon 
loading value. One conclusion that could be drawn from this comparison is the fact that a raw 
water source with a lower DOC concentration will be able to stay on-line longer before reaching 
a threshold TMP value.  This compared to water with a higher DOC concentration, which fouls 
the membrane much quicker, and therefore reaches its TMP threshold (12 psi). Just the same, 
water treatment researchers can utilize this method of presenting data to optimize bench and pilot 
scale membrane systems. The DOC concentration is a very crucial parameter in quantifying the 
fouling rate, membrane life span, and overall finished water quality; and both alternative 




CHAPTER 6  
CONCLUSIONS AND RECOMMENDATIONS 
6.1 Conclusions 
The following conclusions are primarily focused on the reduction of TMP across the surface of a 
UF membrane. Fouling mitigation was quantified by measuring the TMP over a 3-day period, 
and plotted against time. The resulting trends were analyzed and several observations were 
described in this thesis. A lower TMP represented a reduction in membrane fouling, as the 
highest TMP and fouling effect was observed when raw water was treated without the use of a 
coagulant pre-treatment. Based on the work presented in this thesis, the following conclusions 
can be made: 
 
1. Under optimal coagulant dose conditions: 
a. Grand River trials: Alum performed best at reducing the membrane 
fouling, in doing so, reducing the TMP pressure observed over a 3-day 
trial period from 12.5 to 5.7 psi, representing a 57 % reduction in overall 
TMP. The three other coagulants yielded TMP reductions of 44 %, 46 % 
and 40 % for ferric chloride SP and SP 70 respectively 
b. Lake Ontario trials: The two pre-hydrolyzed coagulants performed the 
best at reducing the membrane fouling, in doing so, reducing the TMP 
pressure observed over a 3-day trial from 6.2 to 5.0 and 4.9 psi for SP and 
SP 70 respectively. This represented a 20 % and 22 % reduction for the 
two coagulants. The two other coagulants yielded TMP reductions of 12 
%, 15 % for alum and ferric chloride respectively.  
 
The subsequent conclusions (2-9) were extracted from trials conducted with raw 
Grand River water: 
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2. An equal molar dose was established by taking an average of all four coagulant 
doses used during the baseline trials, which corresponded to a dose of 1.75x10-5 
mol metal/L. Increased TMP pressures were observed when equal molar metal 
dosing was utilized. SP performed the best at reducing the membrane fouling, 
with a final TMP of 8.7 psi, representing a 30 % reduction in overall TMP. The 
three other coagulants yielded TMP reductions of 14 %, 24 % and 18 % for alum 
ferric chloride and SP 70 respectively. The results observed with the two PACl 
products and ferric chloride were attributed to under-dosing, where not enough 
coagulant was supplied to accommodate the particle concentration in the raw 
water. Alum was the sole coagulant whose equal molar dose was higher than the 
optimal dose (17 mg/L higher), therefore, a re-suspension of particles likely 
occurred, similar to results described with the jar test trials, and subsequently a 
smaller portion of the solids in the raw water flocculated, and more membrane 
fouling was observed. 
 
3. Membrane trials conduced with modified mixing intensities, coupled with optimal 
coagulant doses yielded increased TMP’s for all four coagulants in comparison to 
the base-line line trials. The elevated mixing intensity from 30 to 45 rpm resulted 
in a larger fraction of the flocs being transferred from the flocculation tank to the 
membrane tank. This contributed to a faster forming organic cake layer on the 
surface of the membrane. The increases were 24 %, 12 %, 17 % and 18 % for 
alum, ferric chloride, SP and SP 70 respectively. These results were heavily 
attributed to the design of the bench scale membrane treatment system which 
induced a larger concentration of flocs in the membrane tank.  
 
4. Membrane trials conduced with modified raw water pH, coupled with optimal 
coagulant doses yielded a reduction in TMP membrane for all four coagulants 
when compared with trials conducted with no pH adjustment. The three aluminum 
based coagulants had their respective raw water pH levels lowered to 5.5, while 
the ferric chloride trial was conducted at a pH level of approximately 5.0. As 
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compared to the base-line trials, the differences in TMP were 4 %, 5 %, 6 % and 6 
% for alum, ferric chloride, SP and SP 70 respectively. 
 
5. Two membrane trials were conducted with half the optimal dose; these trials were 
carried out at doses of 15 mg/L and 20 mg/L for alum and SP respectively. As 
expected, these experiments results in severe under dosing of the coagulants, 
resulting in an elevated rate of TMP increase over the duration of the 3 day trial. 
The TOC removals for the half optimal dose trials were 42 % and 31 % for alum 
and SP respectively, as compared to 59 % and 52 % for the same coagulants, 
representing a decrease of 71 % and 60 % reduction for alum and SP respectively. 
The TOC removals were substantially lower as compared to the base-line optimal 
dose trials. These results were attributed entirely to the under-dosing of both 
coagulants. Shrive et al., (1999). These trends were also observed in the jar test 
trials, as the lower than optimal doses yielded minimal TOC removals for both 
coagulants. 
 
6. Overall, the water quality results complemented the TMP trends observed during 
the membrane trials. High TOC removals were observed during the membrane 
trials conducted with optimal coagulant doses for both the Grand River and Lake 
Ontario water. The optimal Grand River trials yielded TOC removals of 59 %, 65 
%, 52 % and 47 % for alum, ferric chloride, SP and SP 70 respectively. These 
results corresponded reasonably well with those observed during the jar test trials; 
which where 53 %, 39 %, 56 % and 64 % for the same order of coagulants. The 
TOC removals for the membrane trials conducted with Lake Ontario water 
yielded TOC removals of 36 %, 31 %, 30 % and 24 % for alum, ferric chloride, 
SP and SP 70 respectively Unlike the Grand River trials, these results did not 
correspond very well with the results obtained with the Lake Ontario jar test trials. 
The jar test TOC removals were substantially higher: 12 %, 19 %, 17 % and 18 % 
higher for alum, ferric chloride, SP and SP 70 respectively. This was attributed to 
the experimental conditions that were observed, as the jar test trials represented 
ideal coagulation conditions. 
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When the raw Grand River water pH was modified, TOC removals were slightly 
elevated, as a result of the optimized coagulation conditions. The removals were 
increased by 2-5 % across all four coagulants. The elevated mixing rates also 
caused a slight increase in TOC removal, although these results were countered 
with the fact that an increased rate of fouling was also observed. The TOC 
removals were increased by 2-3 %, except for the alum, which did not show an 
increased TOC removal. 
 
7. The fractionation work conducted with raw and treated Grand River water was an 
innovative component of this research. The raw water fractionation experiments 
demonstrated that the majority of the TOC was distributed into two ranges; 
components larger than 30,000 Da, and small than 500 Da. The fractionation 
experiments conducted with treated water showed that the TOC fraction that was 
best removed by the pre-treatment membrane system was the largest fraction 
(larger than 30,000 Da). It was concluded that this fraction was responsible for the 
fouling, as it could have been removed by the coagulation process, and was 
potentially never exposed to the membrane surface. Further investigations would 
have to be conducted that included the fractionation of flocculated water, to make 
a more accurate assessment of what fractions of the NOM contributed to 
membrane fouling. The fractionation results did not vary a great deal when pH 
adjusted treated water was used, as compared to the base-line optimal dose treated 
water.  
 
8. The residual metal analysis yielded very productive results. There were a total of 
six exceedances observed. Five trials conducted with the PACl products yielded 
exceedances These results were attributed to the coagulants reduced ability to 
perform the hydrolysis reactions to produce hydrogen ions. The only other results 
that stood out were those obtained with the equal molar dosing trial conducted 
with alum. This was attributed to the fact that the coagulant was over dosed, and 
the excess coagulant did not participate in the coagulation flocculation step, 
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subsequently it remained in solution and passed through the membrane pores, 
ending up in the permeate stream.  
 
9. The TSS and conductivity analysis yielded results that were expected. The TSS of 
the raw and flocculated waters were similar, and the treated water TSS was 
consistently between 0.3 – 0.4 mg/L, yielding a 99 % TTS removal efficiency by 
the membrane. This was anticipated, as the UF membrane used throughout the 
duration of this project targeted particles that contribute to the TSS and turbidity 
of the water. The conductivity of the water was not affected by the treatment 
process, which was predicted given that neither the coagulation nor the membrane 
targeted the ions that contribute to conductivity. The only trend observed was that 
with the flocculated water values were elevated by 18-20 %, induced by the 


















The following recommendations should be considered to expand upon the work completed for 
this thesis: 
 
1. The following is a list of recommendations that should be considered if any future 
fractionation experiments are to be conducted surrounding this research: 
a. There are several fractionation methods that can be incorporated into 
drinking water treatment research. This project only utilized variation in 
the MWCO of the NOM. Future work should incorporate the 
hydrophobicity of the NOM, as the hydrophobic fraction of the NOM 
controls the coagulant demand (Sharp et al., 2006). This can be 
accomplished by performing resin fractionations on the raw and treated 
water, which separates the hydrophilic and hydrophobic fractions of the 
NOM. The combination of the methods would have the potential of 
producing results that would enhance the understanding of what fractions 
of the NOM contribute to fouling most.  
b. In order to be able to make a more accurate conclusion regarding what 
fractions of the NOM contribute to fouling most, the flocculated water 
would have to be fractionated as well. This project involved the 
fractionation of raw and treated waters, and not the water that exited the 
flocculation tank (floc water). Future experiments should involve the 
fraction of all three water types. This would allow the comparison of 
treated waters vs. floc water, in doing so, isolating the fraction of NOM 
that remained on surface and inside the pores of the membrane module  
 
2. Another way to expand on this research, while still keeping the 
experimental design in tact, is to conducted trials with a membrane 
module position horizontally, as opposed to vertically, which is the way it 
was set up for the duration of the all the experiments. One of the 
fundamental flaws of the air sparging method is that there are only four 
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holes through which the air was able to exit. All four of these holes were 
located at the bottom of the module, resulting in an uneven distribution of 
air throughout the fibres. The bottom half of a vertically fixed module 
does not receive nearly as much air flow, given the vertical set-up and lack 
of air holes. All the air is propelled upwards, and exits between the fibres 
at the top of the module. Over the duration of a 3-day trial, the bottom half 
of the individual fibres were noticeably dark, with a larger amount of 
particles adsorbed to the surface. If the membrane was positioned 
horizontally, with more air holes distributed throughout the module, the air 
sparging would be able to reach nearly the entire length of the module, and 
subsequently a more consistent re-suspension of particles would occur. 









Figure 6-2: Vertical air sparging 
 
The first figure shows the ideal set-up, where the air flows horizontally. Although 
it would be expected to observe the majority of the air bubbles escape through the 
first set of holes in the module, still the distribution would be much improved as 
compared to the later figure, which shows very little air sparging through the 
bottom half of the membrane. 
 
3. Future experiments should be conducted with a similar experimental design, but 
with a micro-filtration membrane, as opposed to the ultra-filtration one used for 
all the experiments in this research. Some experiments suggest that micro-
filtration membranes may be more affected by particulate matter than the ultra-
filtration membranes used (Howe and Clark, 2006). It would be interesting to 
compare fouling rates, TOC/turbidity removals, and residual metal concentrations 
when a micro-filtration membrane is utilized. 
 
4. Future experiments should also be conducted during different times of the year. 
All of the membrane trials were conducted between August and December 2006, 
and therefore no results were obtained to represent spring time conditions, where 
melting snow/run-off has a large effect on the NOM composition in the water. If 
this research was part of a PhD project, a selected few membrane trials would be 
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repeated every two months, so to able to assess how the seasonal variations effect 
fouling and TOC removal. 
 
5. This experimental set-up was designed to simulate a settled water membrane 
treatment system. The majority of the generated flocs remained in the flocculation 
tank, but still there was a fraction that was transferred over to the membrane tank. 
This affected the results, demonstrated with the membrane trials conducted with 
an elevated mixing rate. The higher mixing rate induced the transfer of more flocs 
into the membrane tank, and subsequently more fouling occurred. It would be 
interesting to observe the fouling trends if a secondary tank was introduced, 
located between the flocculation tank and membrane tank. This would ensure that 
a very small amount of flocs made it to the membrane tank. This comparison 
would allow one to assess whether the flocs that were transferred during the trials 
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Figures A.1-A.3: Alkalinity – 175 mg CaCO3/L, Turbidity – 20 NTU 
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Residual Turbidity (Alk-175mg/L) Residual TOC (Alk-175mg/L)  
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Figures A.4-A.6: Alkalinity – 30 mg CaCO3/L, Turbidity – 20 NTU 
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Residual Turbidity (Alk-30mg/L) Residual TOC (Alk-30mg/L)  
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Residual Turbidity (Alk-30mg/L) Residual TOC (Alk-30mg/L)  
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Figures A.7-A.9: Alkalinity – 175 mg CaCO3/L, Turbidity – 5 NTU 
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Residual Turbidity (Alk-100mg/L) Residual TOC (Alk-100mg/L)  
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Figures A.10-A.12: Alkalinity – 175 mg CaCO3/L, Turbidity – 20 NTU 









0.0 1.0 1.9 2.9 3.9 4.8


























































Residual Turbidity (Alk-175mg/L) Residual TOC (Alk-175mg/L)
Residual DOC (Alk-175mg/L  
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Figures A.13-A.15: Alkalinity – 175 mg CaCO3/L, Turbidity – 5 NTU 
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Residual Turbidity (Alk-175mg/L) Residual TOC (Alk-175mg/L) Residual DOC (Alk-175mg/L)  
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Residual Turbidity (Alk-175mg/L) Residual TOC (Alk-175mg/L) Residual DOC (Alk-175mg/L)  
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Figures A.16-A.18: Alkalinity – 100 mg CaCO3/L, Turbidity – 5 NTU 
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Residual Turbidity (Alk-100mg/L) Residual TOC (Alk-100mg/L) Residual DOC (Alk-100mg/L)  
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Figures A.19-A.21: Alkalinity – 30 mg CaCO3/L, Turbidity – 20 NTU 
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Figures A.22-A.24: Alkalinity – 175 mg CaCO3/L, Turbidity – 20 NTU 
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Figures A.25-A.27: Alkalinity – 30 mg CaCO3/L, Turbidity – 20 NTU 









0.0 0.4 0.7 1.1 1.5 1.8






























































Residual Turbidity (Alk-30mg/L) Residual TOC (Alk-30mg/L) Residual DOC (Alk-30mg/L)  
 









0.0 0.4 0.7 1.1 1.5 1.8
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before after ∆ before after ∆ (Y/N)
1 0 0 0.0 13.1 0.62 0.61 0.01 8.13 8.13 0.00 N 2.5 0.0% 2.23 89.2%
2 5 2.9E-05 0.3 13.2 0.62 0.43 0.19 8.11 8.09 0.02 Y 2.21 11.6% 2.01 91.0%
3 10 5.8E-05 0.6 13.1 0.65 0.21 0.44 8.18 7.99 0.19 Y 1.29 48.6% 1.19 92.2%
4 20 1.2E-04 1.2 13.0 0.69 0.2 0.47 8.17 7.81 0.36 Y 1.31 47.6% 1.3 99.2%
5 30 1.8E-04 1.8 13.3 0.67 0.6 0.09 8.20 7.69 0.51 Y 1.67 33.2% 1.48 88.6%
6 40 2.3E-04 2.3 13.4 0.62 0.9 -0.27 8.19 7.58 0.61 Y 1.91 23.6% 1.65 86.4%
DOC %
Turbidity (NTU) pH
TOC DOC% removalJar # [Alum] mg/L) (mol Al / L) Temp (
o
C)




Lake Ontario 2.51 mg/L TOC





before after ∆ before after ∆ (Y/N)
1 0 0 0 13.1 0.61 0.6 0.03 8.22 8.23 -0.01 N 2.41 0.0% 2.21 91.7%
2 5 3.1E-05 0.3 13.2 0.66 0.43 0.23 8.19 8.17 0.02 N 2.03 15.8% 1.84 90.6%
3 10 6.2E-05 0.6 13.1 0.67 0.39 0.28 8.23 8.04 0.19 Y 1.68 30.3% 1.48 88.1%
4 20 1.2E-04 1.2 13.0 0.70 0.15 0.55 8.20 7.81 0.39 Y 1.12 53.5% 0.99 88.4%
5 30 1.8E-04 1.8 13.3 0.68 0.85 -0.17 8.23 7.58 0.65 Y 1.54 36.1% 1.28 83.1%
6 40 2.5E-04 2.5 13.4 0.69 0.99 -0.30 8.19 7.44 0.75 Y 1.98 17.8% 1.77 89.4%
DOC %
Turbidity (NTU) pH
TOC DOC% removalJar # [Alum] mg/L) (mol Al / L) Temp (
o
C)




Lake Ontario 2.41 mg/L TOC

















before after ∆ before after ∆ (Y/N)
1 0 0 0 13.1 0.58 0.59 -0.01 8.18 8.17 0.01 N 2.47 0.0% 2.23 90.3%
2 5 4.9E-05 0.5 13.2 0.62 0.51 0.11 8.19 8.14 0.05 N 2.45 0.8% 2.04 83.3%
3 10 9.7E-05 1.0 13.1 0.61 0.48 0.13 8.20 8.06 0.14 Y 1.89 23.2% 1.68 88.9%
4 20 1.9E-04 1.9 13.0 0.59 0.40 0.19 8.14 7.94 0.20 Y 1.42 42.0% 1.31 92.3%
5 30 2.9E-04 2.9 13.3 0.58 0.41 0.17 8.14 7.85 0.29 Y 1.78 27.6% 1.64 92.1%
6 40 3.9E-04 3.9 13.4 0.63 0.49 0.14 8.19 7.79 0.40 Y 1.86 24.4% 1.66 89.2%
DOC %
Turbidity (NTU) pH
TOC DOC% removalJar # [Alum] mg/L) (mol Al / L) Temp (
o
C)




Lake Ontario 2.47 mg/L TOC





before after ∆ before after ∆ (Y/N)
1 0 0 0 13.1 0.66 0.65 0.01 8.11 8.09 0.02 N 2.49 0.0% 2.28 91.6%
2 5 4.6E-05 0.5 13.2 0.68 0.87 -0.19 8.14 8.03 0.11 N 2.41 3.2% 2.19 90.9%
3 10 9.2E-05 0.9 13.1 0.65 0.16 0.49 8.14 7.99 0.15 Y 1.31 47.2% 1.18 90.1%
4 20 1.8E-04 1.8 13.0 0.69 0.15 19.5 8.19 7.92 0.27 Y 1.33 46.4% 1.09 82.0%
5 30 2.8E-04 2.8 13.3 0.60 0.78 -0.18 8.14 7.82 0.32 Y 1.81 27.2% 1.55 85.6%
6 40 3.7E-04 3.7 13.4 0.61 0.82 -0.21 8.20 7.79 0.41 Y 1.95 21.6% 1.73 88.7%
DOC %
Turbidity (NTU) pH
TOC DOC% removalJar # [Alum] mg/L) (mol Al / L) Temp (
o
C)




Lake Ontario 2.49 mg/L TOC








































before after ∆ before after ∆ (Y/N)
1 0 0 0.0 23.1 7.9 7.8 0.10 7.91 7.90 0.01 N 5.31 0.0% 5.02 94.5%
2 20 1.2E-04 1.2 23.1 8.1 1.4 6.72 7.88 7.61 0.27 Y 2.91 45.2% 2.4 82.5%
3 30 1.8E-04 1.8 23.1 8.2 1.3 6.90 7.83 7.53 0.30 Y 2.38 55.2% 2.10 88.2%
4 40 2.3E-04 2.3 23.3 7.9 0.7 7.20 7.91 7.42 0.49 Y 2.61 50.8% 2.24 85.8%
5 50 2.9E-04 2.9 23.2 8.0 0.5 7.50 7.92 7.30 0.62 Y 2.9 45.4% 2.7 93.1%
6 60 3.5E-04 3.5 23.1 8.2 0.7 7.50 7.94 7.21 0.73 Y 2.7 49.2% 2.5 92.6%
DOC %
Turbidity (NTU) pH
TOC DOC% removalJar # [Alum] mg/L) (mol Al / L) Temp (
o
C)




Grand River 5.31 mg/L TOC





before after ∆ before after ∆ (Y/N)
1 0 0 0 23.1 7.9 8.0 -0.10 7.91 7.88 0.03 N 5.31 0.0% 5.02 94.5%
2 20 1.2E-04 1.2 23.1 8.1 9.8 -1.70 7.88 7.60 0.28 Y 4.713 11.2% 4.03 85.5%
3 30 1.8E-04 1.8 23.1 8.2 3.1 5.10 7.88 7.55 0.33 Y 3.58 32.6% 3.01 84.1%
4 40 2.5E-04 2.5 23.3 7.9 1.1 6.80 7.87 7.48 0.39 Y 3.17 40.3% 2.76 87.1%
5 50 3.1E-04 3.1 23.2 8.0 1.5 6.50 7.86 7.31 0.55 Y 3.37 36.5% 2.86 84.9%
6 60 3.7E-04 3.7 23.1 8.2 2.1 6.07 7.91 7.05 0.86 Y 3.1 41.6% 2.51 81.0%
DOC %
Turbidity (NTU) pH
TOC DOC% removalJar # [FicC] mg/L) (mol Fe / L) Temp (
o
C)




Grand River 5.31 mg/L TOC


















before after ∆ before after ∆ (Y/N)
1 0 0 0 23.1 8.10 8 0.1 7.86 7.86 0.00 N 5.31 0.0% 5.02 94.5%
2 20 1.9E-04 1.9 23.1 8.00 0.87 7.13 7.88 7.74 0.14 Y 2.94 44.6% 2.62 89.1%
3 30 2.9E-04 2.9 23.1 7.90 0.54 7.36 7.88 7.68 0.20 Y 2.56 51.8% 2.33 91.0%
4 40 3.9E-04 3.9 23.3 8.10 0.77 19.5 7.87 7.61 0.26 Y 2.09 60.6% 1.82 87.1%
5 50 4.9E-04 4.9 23.2 8.20 0.88 7.32 7.86 7.54 0.32 Y 1.84 65.3% 1.64 89.1%
6 60 5.8E-04 5.8 23.1 8.00 2.1 5.9 7.88 7.42 0.46 Y 1.97 62.9% 1.7 86.3%
DOC %
Turbidity (NTU) pH
TOC DOC% removalJar # [FicC] mg/L) (mol Fe / L) Temp (
o
C)




Grand River 5.31 mg/L TOC





before after ∆ before after ∆ (Y/N)
1 0 0 0 23.1 9.20 9.1 0.1 7.86 7.86 0.00 N 5.44 0.0% 5.02 92.3%
2 20 1.8E-04 1.8 23.1 9.40 0.87 8.53 7.88 7.78 0.10 Y 3.32 37.5% 3.11 93.7%
3 30 2.8E-04 2.8 23.1 9.50 0.54 8.96 7.88 7.65 0.23 Y 2.28 57.1% 2.14 93.9%
4 40 3.7E-04 3.7 23.3 9.10 0.77 19.5 7.87 7.42 0.45 Y 1.77 66.7% 1.59 89.8%
5 50 4.6E-04 4.6 23.2 9.40 0.88 8.52 7.86 7.40 0.46 Y 1.73 67.4% 1.62 93.6%
6 60 5.5E-04 5.5 23.1 9.60 2.1 7.5 7.88 7.28 0.60 Y 3.11 41.4% 2.88 92.6%
DOC %
Turbidity (NTU) pH
TOC DOC% removalJar # [FicC] mg/L) (mol Fe / L) Temp (
o
C)




Grand River 5.44 mg/L TOC








































































Figure C.1: Grand River water 3 day membrane trial  







































Figure C.2: Raw Grand River water - 3 day membrane trial                                                 










































Figure C.3: Raw Grand River water - 3 day membrane trial                                                 










































              Figure C.4: Raw Grand River water - 3 day membrane trial                                           













































Figure C.5: Raw Grand River water - 3 day membrane trial                                                 
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Figure C.7: Raw Lake Ontario water - 3 day membrane trial                                                






































Figure C.8: Raw Lake Ontario water - 3 day membrane trial                                                
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Figure C.9: Raw Lake Ontario water - 3 day membrane trial                                                









































Figure C.10: Raw Grand River water - 3 day membrane trial                                               









































Figure C.11: Raw Grand River water - 3 day membrane trial                                           
(equal molar metal dose 7.5 x 10
-5










































Figure C.12: Raw Grand River water - 3 day membrane trial                                            
(equal molar metal dose 7.5 x 10
-5













































Figure C.13: Raw Grand River water - 3 day membrane trial                                           
(equal molar metal dose 7.5 x 10
-5










































Figure C.14: Raw Grand River water - 3 day membrane trial                                           
(equal molar metal dose 7.5 x 10
-5










































Figure C.15: Raw Grand River water - 3 day membrane trial                                           







































Figure C.16: Raw Grand River water - 3 day membrane trial                                           












































Figure C.17: Raw Grand River water - 3 day membrane trial                                           










































Figure C.18: Raw Grand River water - 3 day membrane trial                                           



































Figure C.19: Raw Grand River water - 3 day membrane trial                                             










































Figure C.20: Raw Grand River water - 3 day membrane trial                                            






































Source water Grand River
pH 8.1
Sample time TOC DOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 6.54 6.22 10.12 - 7.81 -
1-day 5.79 5.75 0.11 - 7.68 11.5%
2-day 5.81 5.77 0.10 - 7.77 11.2%





Source water Grand River
pH 8.1
Sample time TOC DOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 6.62 6.25 10.12 - 7.81 -
1-day 2.69 2.6 0.11 2.88 7.11 59.4%
2-day 2.7 2.64 0.10 2.79 7.21 59.2%





Source water Grand River
pH 7.88
Sample time TOC DOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 6.71 6.29 9.23 - 7.89 -
1-day 2.32 2.28 0.08 2.34 7.29 65.4%
2-day 2.22 2.19 0.06 2.89 7.30 66.9%





Source water Grand River
pH 7.88
Sample time TOC DOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 6.36 5.99 8.12 - 7.93 -
1-day 3.4 3.31 0.12 3.1 7.48 46.5%
2-day 3.29 3.28 0.08 3.19 7.61 48.3%







Source water Grand River
pH 7.88
Sample time TOC DOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 6.17 5.61 5.21 - 7.91 -
1-day 3.05 3.38 0.1 2.12 7.41 50.6%
2-day 2.92 3.16 0.06 2.56 7.38 52.7%
3-day 2.9 3.3 0.09 1.99 7.44 53.0%  
 






Source water Lake Ontario
pH 8.04
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 2.72 2.34 N/A 0.61 N/A 8.11 -
1-day 2.363 2.33 N/A 0.06 N/A 8.08 13.1%
2-day 2.247 2.2 N/A 0.04 N/A 8.12 17.4%





Source water Lake Ontario
pH 8.23
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 2.78 2.22 - 5.21 - 7.91 -
1-day 1.71 1.7 2.09 0.1 0.38 7.51 38.5%
2-day 1.82 1.78 2.13 0.06 0.29 7.48 34.5%





Source water Lake Ontario
pH 8.32
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 2.633 2.21 - 0.66 - 8.11 -
1-day 1.74 1.71 2.561 0.08 0.61 7.39 33.9%
2-day 1.87 1.78 2.489 0.06 0.53 7.32 29.0%








Source water Lake Ontario
pH 8.34
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 2.71 1.84 - 0.38 0.38 8.06 -
1-day 1.901 1.758 0.57 0.06 0.25 7.81 29.9%
2-day 1.88 1.691 0.44 0.04 0.21 7.75 30.6%





Source water Lake Ontario
pH 8.32
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 2.524 2.311 - 0.62 - 8.23 -
1-day 1.859 1.811 2.418 0.05 0.31 8.02 26.3%
2-day 2.004 1.923 2.481 0.08 0.34 7.83 20.6%
3-day 1.971 1.854 2.332 0.06 0.56 7.92 21.9%  
 






Source water Grand River
pH 7.88
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 6.17 5.61 - 5.21 - 7.91 -
1-day 3.57 3.55 4.79 0.1 4.11 7.41 42.1%
2-day 3.62 3.58 5.12 0.06 3.82 7.38 41.3%





Source water Grand River
pH 8.14
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 6.31 5.61 - 4.99 - 8.11 -
1-day 3.21 3.18 4.18 0.1 5.93 7.44 49.1%
2-day 3.33 3.3 4.22 0.12 5.61 7.39 47.2%








Source water Grand River
pH 8.14
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 6.31 6.25 - 4.99 - 8.11 -
1-day 3.66 3.62 4.22 0.1 2.81 7.44 42.0%
2-day 3.58 3.5 4.39 0.12 3.04 7.39 43.3%





Source water Grand River
pH 7.88
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 6.17 5.61 - 5.21 - 7.91 -
1-day 4.12 4.04 4.04 0.1 3.41 7.41 33.2%
2-day 3.98 3.94 4.11 0.12 3.21 7.38 35.5%
3-day 3.96 3.91 3.87 0.11 3.17 7.44 35.8%  
 
Tables D.15-D.18: Grand River membrane trials data using optimal coagulant doses with 






Source water Grand River
pH 7.99
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 6.32 6.11 - 6.81 - 8.06 -
1-day 2.23 2.2 3.13 0.06 2.23 5.43 64.7%
2-day 2.18 2.15 2.89 0.09 2.41 5.49 65.5%





Source water Grand River
pH 8.32
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 6.21 5.99 - 5.55 - 7.99 -
1-day 3.18 3.15 3.15 0.09 2.81 5.67 48.8%
2-day 3.1 3.06 3.22 0.1 2.99 5.7 50.1%








Source water Grand River
pH 8.11
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 6.08 5.81 - 5.91 - 8.11 -
1-day 2.91 3.38 2.98 0.09 3.45 5.55 52.1%
2-day 2.84 3.16 2.91 0.09 3.18 5.61 53.3%





Source water Grand River
pH 8.01
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 6.31 6.05 - 0.62 - 7.94 -
1-day 2.12 2.05 2.21 0.09 3.87 4.89 66.4%
2-day 2.09 2.02 2.11 0.06 3.56 4.81 66.9%
3-day 2.11 2.04 2.09 0.07 3.77 4.99 66.6%  
 
Tables D.19-D.22: Grand River membrane trials data using optimal coagulant doses with 





Source water Grand River
pH 7.99
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 6.11 5.81 - 7.12 - 8.06 -
1-day 2.42 2.4 4.67 0.11 2.31 7.11 60.4%
2-day 2.51 2.47 4.41 0.10 2.91 7.21 58.9%





Source water Grand River
pH 8.01
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 6.34 6.28 - 0.62 - 7.94 -
1-day 1.88 2.04 2.44 0.10 4.18 7.22 70.3%
2-day 1.91 1.89 2.61 0.11 4.22 7.18 69.9%









Source water Grand River
pH 8.32
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 6.28 5.61 - 0.62 - 8.11 -
1-day 2.81 2.77 3.13 0.06 3.45 7.34 55.3%
2-day 2.76 2.7 3.41 0.05 3.18 7.29 56.1%






Source water Grand River
pH 8.32
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 6.34 5.81 - - - 7.99 -
1-day 3.11 3.09 3.99 0.09 3.14 7.44 50.9%
2-day 2.99 2.96 3.87 0.11 2.99 7.52 52.8%
3-day 3.08 3.04 3.81 0.07 3.47 7.4 51.4%  
 






Source water Grand River
pH 8.11
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 5.85 5.49 - 5.98 - 8.01 -
1-day 3.24 3.2 5.21 0.10 5.23 7.66 44.6%
2-day 3.57 3.52 5.11 0.12 5.15 7.59 39.0%





Source water Grand River
pH 8.04
Sample time TOC DOC Floc TOC Turbidity Floc Turb pH TOC Removal
 0 (RAW) 5.94 5.61 - 6.11 - 8.06 -
1-day 4.11 4.04 4.91 0.07 5.45 7.71 30.8%
2-day 4.01 3.94 4.94 0.09 5.63 7.74 32.5%
3-day 4.23 4.19 5.15 0.10 5.99 7.75 28.8%  
